WO2018021816A1 - Anticancer injection preparation device and anticancer injection preparation system comprising same - Google Patents

Anticancer injection preparation device and anticancer injection preparation system comprising same Download PDF

Info

Publication number
WO2018021816A1
WO2018021816A1 PCT/KR2017/008039 KR2017008039W WO2018021816A1 WO 2018021816 A1 WO2018021816 A1 WO 2018021816A1 KR 2017008039 W KR2017008039 W KR 2017008039W WO 2018021816 A1 WO2018021816 A1 WO 2018021816A1
Authority
WO
WIPO (PCT)
Prior art keywords
anticancer
injection
anticancer agent
supply unit
unit
Prior art date
Application number
PCT/KR2017/008039
Other languages
French (fr)
Korean (ko)
Inventor
박석훈
이찬호
홍일화
Original Assignee
큐렉소 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 큐렉소 주식회사 filed Critical 큐렉소 주식회사
Publication of WO2018021816A1 publication Critical patent/WO2018021816A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms

Definitions

  • the present invention relates to an anticancer injection preparation device and an anticancer injection preparation system including the same, and more particularly, an anticancer injection that can prepare an anticancer injection by minimizing waste of drugs through an automated facility and extracting quantitative anticancer drugs and sap.
  • the present invention relates to a preparation device and an anticancer injection preparation system including the same.
  • anticancer injections are used in a form in which intravenous injection is possible by mixing an anticancer agent with a certain amount of fluid.
  • the pharmacist extracts and mixes the anticancer agent and the sap manually, and thus it is difficult to quantitatively and accurately determine whether or not the correct preparation is made. Therefore, an incorrect amount is prepared according to the manual operation, thereby increasing the risk of patients using anticancer injections. .
  • the pharmacist extracts and mixes the anticancer agent and the sap manually according to the judgment of the pharmacist, thereby increasing the amount of work of the pharmacist and difficulty in preparing a quantitative anticancer injection.
  • the present invention has been made to solve the above problems of the prior art, by reducing the intervention of the pharmacist through an automated facility to extract the quantitative anticancer and sap and to check the mixed amount of the mixed anticancer injection, reducing the manpower and pharmacist It is an object of the present invention to provide an anticancer injection preparation device and an anticancer injection preparation system including the same, which can ensure the safety of the drug and prepare a quantitative anticancer injection.
  • a sterile preparation stage is provided in the sterile chamber is provided with a preparation chamber for preparing an anticancer injection;
  • a drug supply unit installed in the sterile preparation station and fixed with a plurality of anticancer agent vials containing an anticancer agent, and selecting any one of a plurality of anticancer agent vials to supply an anticancer agent;
  • An injection device operable to be aligned with a location of an anticancer agent vial installed in the drug supply unit, and extracting an anticancer agent from the anticancer agent vial installed in the drug supply unit and injecting the anticancer agent extracted into the place where the sap is accommodated;
  • Sap supply unit is installed in the aseptic preparation, for supplying the sap mixed with the anticancer agent;
  • a mixing unit provided with a mixing container for mixing the anticancer agent supplied from the injection device with the sap supplied from the infusion supply unit.
  • the drug supply unit and the injection device is coupled, the lifting unit for lifting the medicine supply unit and the injection device; And a support part installed on the sterile preparation base and supporting the lifting part, wherein the lifting part is coupled to the support part to be inserted into the support part.
  • the drug supply unit the first fixing member is installed on the sterile preparation table, the anticancer drug vial is arranged in alignment with the injection device while rotating about any one axis of the vertical;
  • a second fixing member installed on the sterile preparation table and installed to allow the anticancer drug vial to be arranged in an arc shape so that the anticancer vial can be aligned with the injection device while rotating about the axis of rotation of the injection device. It is characterized by including.
  • the injection device a syringe for extracting an anticancer agent from the drug supply;
  • a rotating part installed below the syringe and allowing the syringe to rotate toward a position of an anticancer drug vial installed in the medicine supplying part;
  • a first linear installed at an upper portion of the rotating part to allow the syringe to linearly move toward the position of the anticancer drug vial;
  • a second linear installed above the first linear to operate the piston of the syringe to extract or inject the anticancer agent.
  • the sap supply unit the sap bag installation unit is installed sap bag;
  • a first connection tube connected to one side of the sap bag and transferring the sap extracted from the sap bag;
  • a metering pump connected to one side of the first connecting tube and pumping and discharging the pump to be extracted from the sap bag by a predetermined amount through the first connecting tube;
  • a second connecting tube for transferring the sap discharged from the metering pump to the mixing unit.
  • an anticancer bag in which a large amount of anticancer agent is stored is installed in the sap bag installation unit, and a first connection tube is installed to be connected to one side of the anticancer agent bag, thereby allowing a large amount by operation of a metering pump It is characterized in that the anticancer agent can be injected into the mixing vessel through the second connecting tube.
  • the first electronic balance is further installed in the mixing part to check the weight of the anticancer agent and the sap contained in the mixing container.
  • a shaker is further installed in order to inject the sap into the anticancer agent and to mix the anticancer agent in the sap.
  • the method may further include an information input unit for inputting prescription information describing the anticancer injection component, inputting information about the prepared anticancer injection component, and storing the data as data.
  • the information input unit a bar code output unit for outputting the information on the prescription information and the components of the prepared anticancer injection drug delivered through the interlocking hospital network;
  • a barcode reader for reading prescription information and ingredient information of the prepared anticancer injection;
  • a touch screen for displaying and storing the information input through the barcode reader and transmitting the information to the place where the anticancer injection is prepared and the hospital computer network.
  • a plurality of anticancer drug vials containing an anticancer agent are fixed, and any one of a plurality of anticancer drug vials is selected to supply an anticancer drug, and a mixed container for supplying a anticancer agent and an aqueous solution to mix the sap.
  • An anticancer injection preparation device for preparing an anticancer injection using a medicine supply unit and a mixing container supplied from the supply unit;
  • a transport robot for transporting the drug supply unit and the mixed container supplied from the supply unit to the anticancer injection preparation device or for transporting the mixed container containing the drug supply unit and the anticancer injection drug from the anticancer injection device;
  • an ejecting unit for carrying out the medicine supplying unit which is transported from the anticancer injection preparation device and the mixed container containing the anticancer injection by the transfer robot.
  • the anticancer injection preparation system comprises a plurality of the anticancer injection preparation device, the anticancer injection preparation device is characterized in that each installed so that the separation distance from the transport robot is located at the same position.
  • the anticancer injection preparation device and the anticancer injection preparation system including the same according to the present invention have the following effects.
  • the quantitative anticancer agent is extracted from the anticancer agent vial installed in the drug supply unit and injected into the mixing container installed in the mixing unit, and the quantitative sap is extracted from the sap bag installed in the sap supply unit by the metering pump and injected into the mixing container of the mixing unit.
  • anticancer injectable drugs in which a fixed amount of anticancer agent and sap are mixed can be prepared.
  • the anticancer agent is injected into the mixing portion of the mixing unit by using a metering pump, and when a powdered anticancer agent is used, the sap is injected and the anticancer agent is dissolved in the sap through the shaker and mixed.
  • FIG 1 is an overall configuration diagram schematically showing the configuration of an anticancer injection preparation device according to the present invention.
  • Figure 2 is a view showing the main configuration of the anticancer injection preparation device according to the present invention.
  • Figure 3 is a view showing the main components of the anticancer injection preparation device according to another embodiment of the present invention.
  • Figure 4 is a view of the anticancer injection preparation device of the present invention showing a state in which a large amount of anticancer agents are used.
  • Figure 5 is a view showing the main components of the anticancer injection preparation device according to another embodiment of the present invention.
  • 6 and 7 is an operating state diagram showing a schematic operation of the anticancer injection preparation device according to another embodiment of the present invention.
  • FIG. 8 is a schematic operation state diagram showing an anticancer injection preparation system according to the present invention.
  • FIG. 1 is an overall configuration diagram schematically showing the configuration of an anticancer injection preparation device according to the present invention
  • Figure 2 is a view showing the main configuration of the anticancer injection preparation device according to the present invention
  • Figure 3 is an anticancer according to another embodiment of the present invention
  • Fig. 4 shows the main structure of an injection preparation device.
  • Fig. 4 is a view of the anticancer injection preparation device of the present invention showing a state in which a large amount of anticancer drugs are used.
  • the anticancer injection preparation device 1 is largely, a sterile preparation table 10, the drug supply unit 20, the injection device 30, the fluid supply unit 40, It is comprised including the mixing part 50.
  • the present invention relates to an anticancer injection preparation device capable of preparing an accurate anticancer injection.
  • the sterile preparation table 10 provides a space for preparing an anticancer injection.
  • the sterile dispensing table 10 is a support 110 is installed on the ground so that a certain height can be floated from the ground to facilitate the pharmacist or manager, the preparation unit and the preparation work on the support 110 Preparation room 120 is provided with a space for performing this.
  • the sterile preparation table 10 is basically installed in a sterile chamber, and one or two pharmacists per dispensing room 120 may be arranged to perform anticancer injection preparation.
  • the dispensing room 120 is formed in the form of a part when viewed from the front, and may be provided with an extended space therein, the table 121 for placing equipment and drugs is provided, This allows the pharmacist to handle the equipment or drug and perform the preparation.
  • the support 110 may be further provided with a moving means (for example, wheels) and the like in contact with the ground to improve mobility.
  • a moving means for example, wheels
  • the non-defective supply unit 20 is a part for supplying the anticancer agent.
  • the drug supply unit 20 is installed in the preparation chamber 120 of the sterile preparation table 10.
  • the drug supply unit 20 may be attached to a structure such as a separate block is installed, the shape of the block is not limited.
  • the drug supply unit 20 is a part for supplying the anticancer drug and the sap in the preparation of anticancer injections, a plurality of anticancer vials (vial) (3) is installed to continuously supply a large amount of anticancer drugs It is a part.
  • the anticancer drug vial 3 is stored as a pure anticancer drug without the addition of sap, and the inlet is formed to insert the injection needle in the form of a glass bottle.
  • the drug supply unit 20 is configured such that a plurality of anticancer drug vials 3 are installed to continuously perform the anticancer drug extraction.
  • any one of the plurality of anticancer agent vials 3 may be selected to be formed to supply the anticancer agent.
  • the drug supply unit 20 may supply an anticancer agent stored in a container of another type in addition to the anticancer agent vial 3 in some cases.
  • the drug supply unit 20 is configured to include a first fixing member 210 and the second fixing member 220 according to its form.
  • the first fixing member 210 is disposed above the table 121 of the preparation chamber 120 and a rotation shaft 211 is installed to rotate about any axis vertically when viewed from the front, and the The rotating shaft 211 is provided with a jig plate 212 in which the anticancer agent vial 3 is installed.
  • a first clamp 212a is installed at the edge of the jig plate 212 so that a plurality of anticancer vials 3 are disposed and fixed.
  • the rotary shaft 211 is formed so as to be rotated in the vertical phase
  • the jig plate 212 in the form of a circular or square plate is installed on the rotary shaft 211
  • the anticancer agent vial 3 is installed in the clamp 212a so that the anticancer agent vial 3 can be arranged in a specific position as the jig plate 212 is rotated.
  • the position at which the anticancer agent vial 3 is aligned refers to a position coinciding with the position of the injection device 30 described later.
  • the second fixing member 220 is disposed above the table 121 of the preparation chamber 120 such that a plurality of anticancer vials 3 are arranged in an arc shape when viewed from the front. It is formed to be.
  • the second fixing member 220 includes a power unit 221, an arc member 222, and a second clamp 222a.
  • the power unit 221 is installed below the arc member 222, that is, to be disposed inside the arc member 222 when viewed from the front to move the arc member 222 to the left or right.
  • the arc member 222 is formed in the shape of an arc strip (arc) is moved to the left or right on the power unit 221 by the power unit 221, the arc member 222 at a predetermined interval of the anticancer agent A plurality of second clamps 222a are installed to fix the vials 3.
  • the arc member 222 moves to rotate left or right, and the anticancer agent vial 3 fixed to the second clamp 222a is erected vertically in an inclined state. It can be placed in a state.
  • the reference position of the second fixing member 220 may be the same position as the injection device 30.
  • the injection device 30 serves to extract the anticancer agent from the anticancer agent vial 30 or inject into the place where the fluid is accommodated.
  • the injection device 30 is installed above the table 121 of the preparation chamber 120 so that the injection device 30 can be aligned with the anticancer drug vial 3 position of the drug supply unit 20.
  • the anticancer agent vial 30 is installed under the first fixing member 210 and the second fixing member 220 of the chemical supply unit 20 according to the operation of the second fixing member 210 and the second fixing member 220. It is installed so as to correspond to the position of the arrangement.
  • the injection device 30 is a syringe 310 for extracting and injecting an anticancer agent, a rotating part 320 to enable the syringe 310 to rotate in the direction of the drug supply unit 20, the syringe 310 is a drug supply unit ( The first linear 330 to perform a linear movement in the 20) direction, and the second linear 340 to linearly move for the piston operation of the syringe 310.
  • the syringe 310 is able to extract the anticancer agent from the anticancer agent vial 3 or inject the fluid into the position through the piston movement in the state in which the syringe needle is plugged into the anticancer agent vial 3.
  • the rotating part 320 is installed under the syringe 310 to rotate the syringe 310 to be positioned toward the position of the anticancer drug vial 3 installed in the medicine supply part 20.
  • the rotating part 320 is installed to rotate horizontally when viewed from the front.
  • the first linear 330 is installed above the rotating part 320, the syringe 310 is positioned to the position of the anticancer agent vial 3 installed in the first fixing member 210 or the second fixing member 22. It is a part that makes a linear motion so that it can be.
  • the first linear 330 may be a linear motion operation by a general LM guide driving method.
  • the second linear 340 is installed on the first linear 330 and attached to the piston of the syringe 310 to operate the piston of the syringe 310 so that the needle of the syringe 310 is the anticancer vial 3. It is inserted into the entrance of the anticancer drug can be extracted.
  • the second linear 340 may be injected into the mixing unit 50 after the syringe 310 is disposed in the mixing unit 50 position where the syringe 310 is rotated and mixed with the sap to be described later through the rotating unit 320.
  • the syringe 310 may rotate to the anticancer agent vial 3 or the mixing unit 50 position by the rotating unit 320, the anticancer agent vial 3 or the mixing unit 50 through the first linear 330. After approaching to the) position, the operation of extracting and injecting the anticancer agent through the second linear 330 may be implemented.
  • the fluid supply unit 40 is a portion for supplying the fluid required to be mixed with the anticancer agent extracted by the syringe 310 to be prepared as an anticancer injection.
  • the infusion supply unit 40 includes a sap bag installation unit 410, a first connection tube 420, a metering pump 430, and a second connection tube 44.
  • the infusion bag installation unit 410 is installed on the preparation chamber 120 of the sterile preparation table 10.
  • the sap bag installation unit 410 is formed so that the sap bag (2) in which the sap is stored to be installed in a vertical position in order to smoothly supply the sap.
  • the sap bag installation unit 410 may be formed in a ring on the sap bag (2), it may be formed in a bar shape horizontally so that the sap bag (2) can be easily fixed through the ring.
  • the infusion bag installation unit 410 is not limited to the form and may be configured in various forms as long as the infusion bag 2 can be installed so as to be disposed vertically in the preparation chamber 120.
  • the first connection tube 420 is connected to one side of the sap bag (2) is the portion to which the sap extracted from the sap bag (2) is transferred.
  • the metering pump 430 is connected to one side of the first connecting tube 420, the pumping and discharging so that the sap is extracted from the sap bag 2 by a predetermined amount through the first connecting tube 420 Play a role.
  • connection tube 440 is a portion for transferring the sap discharged from the metering pump 430 to the mixing unit 50.
  • a first connecting tube 420 is connected to the sap bag 2 installed in the sap bag installation unit 410, and one side of the first connecting tube 420 is connected to the metering pump 430.
  • One side of the second connection tube 440 is connected to the other side and the other side is installed to be connected to the mixing unit 50.
  • the quantitative pump 430 operates, the sap stored in the sap bag 2 is the first connection tube.
  • the 420 is introduced into the metering pump 430 and the sap can be transferred to the mixing unit 50 through the second connecting tube 440 by the pumping of the metering pump 430.
  • the quantitative sap can be injected into the mixing unit 50 by the quantitative pump 430.
  • first connecting tube 420 and the second connecting tube 440 is preferably a connector for connecting to the sap bag (2) and the like.
  • the metering pump 430 refers to a plunger-type pump used for accurately controlling a very small amount of material into a continuously flowing liquid, and the fluid flowing through the tube tube from one side to the other tube tube.
  • the mixing unit 50 is a portion for mixing and mixing the anticancer agent and the sap.
  • the mixing unit 50 is installed at one side of the preparation chamber 120 of the sterile preparation table 10, and is a portion for mixing the anticancer agent supplied from the injection device 30 and the sap supplied from the sap supply unit 40,
  • the mixing container 5 for accommodating the anticancer agent and the sap is provided.
  • the mixing unit 50 is provided with a container fixing part 510 to fix the mixing container 50, the first electronic balance 520 to check the weight of the anticancer agent and the sap contained in the mixing container (5) It is preferable to install this further.
  • the mixing container 5 installed in the mixing part 50 may be fixed by the container fixing part 510 in a preferably laid horizontal shape, and the injection amount of the anticancer agent and the sap injected into the mixing container 5.
  • the change in weight can be confirmed through the first electronic balance 520.
  • the anticancer agent is extracted from the drug supply unit 20 through the syringe 310 of the injection device 30, and the anticancer agent is injected into the mixing container 5 of the mixing unit 50 by the rotating unit 320, After injecting the quantitative amount of the sap into the mixing container 5 of the mixing part 50 through the supply part 40, the anticancer agent and the sap are collected and mixed in the mixing container 5 so that the anticancer injection can be prepared.
  • the shaker 60 is further installed to inject the sap into the anticancer agent stored in the anticancer agent vial 3 and to mix the anticancer agent in the sap solution. It is preferable.
  • the shaker 60 serves to make the powdered anticancer agent and the sap easily dissolved and mixed.
  • a second electronic balance 610 may be further installed to check whether the fluid is quantified, and the quantitative fluid is injected through the second electronic scale 610. After confirming that the shaker 60 is operated to mix the anticancer agent and the sap.
  • the anticancer agent described above when a large amount of anticancer injections are to be prepared using a large amount of anticancer drugs in addition to the anticancer agent vial (3), in order to inject a large amount of anticancer drugs into a mixed container, 4) is installed in the sap bag installation unit 410, the first connecting tube 420 is installed to be connected to one side of the anticancer agent bag (4), a large amount of anticancer agent by the operation of the metering pump 430 It may be injected into the mixing vessel (5) through the connecting tube (440).
  • an anticancer agent bag 4 containing a large amount of anticancer agent is installed, and the anticancer agent is injected into the mixing container 5 through the metering pump 430. Will be done.
  • an information input unit 70 may be further provided to store prescription information and anticancer drug preparation information as data.
  • the information input unit 70 largely includes a barcode printer 710, a barcode reader 720, and a touch screen 730.
  • the information input unit 70 is a part for receiving and inputting prescription information describing an anticancer injection drug component from a hospital computer network, and inputting information on the components of the prepared anticancer injection drug and storing it as data.
  • the barcode output unit 710 is a part for outputting the prescription information and the information on the components of the prepared anticancer injection drug delivered through the hospital network interlock as a barcode label.
  • the barcode reader 720 is a portion for reading the prescription information and the component information of the anticancer injection drug prepared as data to store.
  • the touch screen 730 displays and stores the information input through the bar code reader 720, and serves to transmit the information to the place where the anti-cancer injection drug and hospital hospital network.
  • the touch screen 730 includes an information processing and computing device in addition to a display function of displaying information, and may be, for example, in the form of an integrated PC.
  • the bar code reader 720 and the bar code output device 710 are configured to be used as a device for inputting and outputting through manipulation of the touch screen 730.
  • the prescription information is displayed and displayed on the touch screen 730 through the hospital computer network, and the pharmacist checks the prescription information and then records the prescription through the barcode printer 710.
  • the bar code label described is output and attached to the mixing container (5).
  • the result information of the anticancer drug preparation component is displayed on the touch screen 730, and the pharmacist outputs the information of the anticancer drug preparation component as a barcode and then the mixed container ( 5) Attach to.
  • the barcode reader 720 reads information about the anticancer drug preparation component and stores the data on the touch screen 730.
  • the pharmacist can check and compare the prescription information and the anticancer injection preparation information, and can store the history of the anticancer injection preparation for each patient as data.
  • the information input unit 70 may input and output the prescription information and the anticancer injection preparation information for the patient as a bar code, and output the data as a bar code so that accurate prescription and preparation for the patient may be performed in connection with the computer network. .
  • the installation position of the chemical supply unit 20, the injection device 30, the fluid supply unit 40, the mixing unit 50, the shaker 60, the information input unit 70 is installed in the aseptic preparation table 10 is limited It does not do but reveals that the fluid can be installed, and the injection device 30 is not limited to a specific position as long as the drug supply unit 20 and the mixing unit 50 can operate in conjunction.
  • the patient's prescription information is transmitted to and displayed on the touch screen 730 through the hospital computer network.
  • the pharmacist checks the information displayed on the touch screen 730, generates prescription information as a barcode, outputs the barcode label through the barcode printer 710, and attaches it to the mixed container 5 for the anticancer injection.
  • the barcode is read through the barcode reader 720 and stored as data.
  • the pharmacist fixes the mixing container 5 to the container fixing part 510 of the mixing part 50, and the anticancer and sap extraction and infusion data according to the prescription through the touch screen 730 drug supply unit 20 And to the injection device 30, the fluid supply unit 40 and the like to make the setting for the operation.
  • the pharmacist performs a task of attaching a prescription input and connector, and installing a medicine.
  • the drug supply unit 20 first supplies the anticancer drug.
  • the jig plate 212 is rotated around the rotating shaft 211, the anticancer vial 3 is the syringe 310 of the injection device 30 ) So that it can be arranged in line with the position.
  • the syringe 310 is rotated toward the anticancer agent vial 3 position by the rotating unit 320, and advanced to the anticancer agent vial 3 position by the first linear 330, and then the second linear 340 is moved.
  • the syringe 310 is operated through the needle to insert the syringe 310 into the anticancer agent vial 3 to extract the anticancer agent.
  • the first linear 330 is moved backward, and then the mixing unit ( The mixing container 5 of 50) rotates to a position where the anticancer agent is injected, and the needle 310 is inserted into the mixing container 5 to inject the extracted anticancer agent into the mixing container 5 as in the operation of extracting the anticancer agent. .
  • the weight of the anticancer agent and the sap injected into the mixing container 5 can be confirmed through the first electronic balance 520.
  • the sap for mixing with the anticancer agent injected into the mixing vessel (5) is the first connecting tube 420 from the sap bag (2) installed in the sap bag installation unit 410 by the operation of the metering pump 430 Through the metering pump 430 through the second connecting tube 440 is to be injected into the mixing vessel (5).
  • the anticancer agent bag 4 is installed in the sap bag installation unit 410 and the first connection tube 420 is connected to the anticancer agent bag 4 through a metering pump 430. It is possible to inject into the mixing vessel (5).
  • the anticancer agent vial 3 is placed in the second electronic balance 610 and then injected with sap to check the mixed weight of the anticancer agent and sap of the powder, and then through the shaker 60.
  • the powdered anticancer agent is mixed so that it can be easily dissolved, and the anticancer agent vial 3 in which the mixing of the anticancer agent and the sap is completed is transferred to the drug supply unit 20 and used.
  • the anticancer injection preparation information is output on the touch screen 730, and the pharmacist checks this information, and then outputs a barcode label containing the preparation result information and attaches the mixed container 5 to the barcode. Read data to the barcode reader 720 to store the data.
  • the finished anticancer injection is then delivered to an outpatient injection room and injected into the patient.
  • the anticancer agent of a certain amount is extracted from the anticancer agent vial 3 installed in the drug supply unit 20 through the injection device 30, and injected into the mixing container 5 installed in the mixing unit 50, and the metering pump ( 430 is extracted from the sap bag (2) installed in the sap supply unit 40 is injected into the mixing container (5) of the mixing section 50 to prepare an anticancer drug injection in which the quantitative anticancer agent and sap is mixed It becomes possible.
  • the anticancer agent when a large amount of anticancer agent is used, the anticancer agent is injected into the mixing container 5 of the mixing unit 50 by using the metering pump 430, and when a powdered anticancer agent is used, infusion of sap is made through the shaker 60.
  • the anticancer agent can be dissolved in the sap and mixed.
  • the automated facility minimizes the intervention of the pharmacist to reduce manpower, secures safety by reducing direct contact with the anticancer agent, and improves the accuracy of the anticancer injection preparation by mixing the quantitative anticancer agent and the sap. Is there.
  • FIG. 5 is a view showing the main configuration of the anticancer injection preparation device according to another embodiment of the present invention
  • Figure 6 and Figure 7 is an operating state showing the schematic operation of the anticancer injection preparation device according to another embodiment of the present invention to be.
  • the anticancer injection preparation device 1 according to another embodiment of the present invention further includes a lift unit 80 and a support unit 90.
  • the medicine supply unit 20 and the injection device 30 may be coupled to the lifting unit 80.
  • the lifting unit 80 may raise and lower the medicine supply unit 20 and the injection device 30.
  • the lifting unit 80 may be coupled to the first fixing member 210 on one side.
  • the drug supply unit 20 may be coupled to the first fixing member 210.
  • the drug supply unit 20 may rotate about the rotation shaft 211 in a state coupled to the first fixing member 210.
  • the lifting portion 80 may be coupled to the support portion 90 on the other side.
  • the lifting unit 80 may be coupled to the support unit 90 to be inserted into the support unit 90.
  • the drug supply unit 20 and the injection device 30 may be coupled to the lifting unit 80 to be located between one side and the other side of the lifting unit 80.
  • the lifting unit 80 may move the drug supply unit 20 and the injection device 30 in an upward direction or a downward direction.
  • the elevating part 80 may be partially or entirely inserted into the support part 90 to move the medicine supply part 20 and the injection device 30 downward.
  • the elevating unit 80 protrudes from the support unit 90 in a direction opposite to the direction of insertion into the support unit 90, thereby moving the drug supply unit 20 and the injection device 30 upward. have.
  • the lifting unit 80 may move the drug supply unit 20 and the injection device 30 downward when the anticancer injection agent is prepared in the sterile preparation table 10.
  • the pharmacist or anticancer injection agent is mounted on the lifting unit 80 or the lifting unit 80 through the open inlet of the aseptic preparation 10
  • the drug supply unit 20 can be removed from the unit 80 and removed.
  • the anticancer agent vials 3 of the drug supply unit 20 are empty. Can be. Therefore, the anticancer injection may be accommodated in the mixing container 5.
  • the lifting unit 80 may be moved downward after the syringe 310 is rotated by the rotating unit 320.
  • the syringe 310 may be rotated by the rotating part 320 in a vertical direction perpendicular to the vertical movement direction of the lifting part 80.
  • the lifting unit 80 may move the new drug supply unit 20 coupled to one side of the lifting unit 80 in the downward direction to be located to the open inlet of the aseptic preparation 10.
  • the elevating unit 80 protrudes from the support unit 90 such that the chemicals
  • the supply unit 20 and the injection device 30 may be moved upward.
  • the anticancer agent vials 3 of the new drug supply unit 20 may be the new anticancer agent vials 3 filled with the anticancer agent installed on the first fixing member 210 by a pharmacist or a pharmacist.
  • the lifting unit 80 may move the new drug supply unit 20 and the injection device 30 upward to prepare an anticancer injection from the new drug supply unit 20.
  • the mixing container 5 into which the anticancer injection is injected may also be replaced by a pharmacist or a formulator with a new mixing container 5 having an empty inside.
  • the elevating unit 80 moves the drug supply unit 20 and the injection device 30 upward, the syringe 310 rotated in the vertical direction again extracts an anticancer agent from the anticancer agent vial 310.
  • Direction can be rotated.
  • the lifting unit 80 may be formed in a cylindrical shape, but is not limited thereto, and may be formed in another shape such as a rectangular parallelepiped if the medicine supply unit 20 and the injection device 30 can be elevated.
  • the lifting unit 80 is a cylinder method using a hydraulic cylinder or a pneumatic cylinder, a gear method using a motor and a rack gear and a pinion gear, a ball using a motor and a ball screw, etc.
  • the chemical supply unit 20 and the injection device 30 may be moved upward and downward by using a screw method, a belt method using a motor, a pulley and a belt, or a linear motor method using a coil and a permanent magnet. Can be.
  • the lifting unit 80 may include an Lm block moving along an Lm guide rail installed in the support unit 90.
  • the support 90 is installed on the aseptic preparation table 10.
  • the support 90 may be installed on the aseptic preparation 10 so as to be located between the metering pump 430 and the second electronic balance 610.
  • the lifting unit 80 may be coupled to the support unit 90 to be insertable.
  • the support 90 may be supported by the aseptic preparation table 10 to support the lifting unit 80.
  • the support portion 90 may be formed as a rectangular parallelepiped in an overall shape, but is not limited thereto.
  • the support portion 90 may support the lifting portion 80, and part or all of the lifting portion 80 may be inserted into the support body 90. If possible, it may be formed in other shapes such as trapezoidal shape with an empty interior.
  • the anticancer injection preparation device 1 can place the drug supply unit 20 to the open inlet of the sterile preparation 2 after the preparation of the anticancer injection is completed.
  • the pharmacist or the pharmacist can easily remove the medicine supply unit 20 from the lifting unit 80 through the open inlet or easily install the lifting unit 80. Therefore, the anticancer injection preparation device 1 according to another embodiment of the present invention can prevent an industrial accident such as a musculoskeletal disorder from occurring in a pharmacist or a preparation person.
  • FIG. 8 is a schematic operation state diagram showing an anticancer injection preparation system according to the present invention.
  • the anticancer injection preparation system 1000 may include a supply unit 1100, an anticancer injection preparation device, a transfer robot 1200, and an export unit 1300. Since the anticancer injection preparation device is substantially the same as the anticancer injection preparation device 1 according to the present invention described above, a detailed description thereof will be omitted.
  • the supply unit 1100 has a plurality of anticancer vials containing an anticancer agent is fixed to any one of the plurality of anticancer vials to supply the drug supply unit 20 for supplying the anticancer agent, and the mixing vessel 5 for mixing the anticancer agent and the sap It is to supply.
  • the supply unit 1100 is the drug supply unit from the outside of the sterile preparation table 2 to the supply transfer area (SA, shown in Figure 8) that the transfer robot 1200 can be transferred to the anticancer injection preparation device (1) (20) and the mixing vessel (5) for supplying. That is, the supply unit 1100 is installed to connect the outside of the sterile preparation table 2 with the supply transfer area SA of the transfer robot 1200.
  • the feed transfer area SA of the transfer robot 1200 may be moved by holding the chemical supply unit 20 and the mixing vessel 5 supplied from the supply unit 1100 by the transfer robot 1200 formed of multiple joints. It means the area that can be.
  • the supply unit 1100 is the drug supply unit 20 and the mixing vessel (5) supplied by the pharmacist or formulator from the outside of the sterile preparation table (2) to the supply transfer area (SA) of the transfer robot 1200 Can supply
  • the supply unit 1100 may be a conveyor capable of supporting and moving the chemical supply unit 20 and the mixing container 5.
  • a pharmacist or pharmacist located outside of the sterile dispensing table 2 may supply the supply unit 1100 with a medicine supply unit 20 containing other types of anticancer agents according to a patient's prescription.
  • the supply unit 1100 may move a plurality of pairs of the chemical supply unit 20 and the mixing vessel (5).
  • the supply unit 1100 by sequentially placing a plurality of drug supply unit 20 and the mixing vessel (5) set by the pharmacist or formulator differently from the outside of the sterile preparation table 2, a plurality of The chemical supply unit 20 and the mixing container 5 may be sequentially moved to the supply transfer area SA.
  • the supply unit 3 supplies a pair of chemical supply unit 20 and the mixing vessel 5 to the supply transfer area SA, the transfer robot 1200 is the pair of chemical supply unit 20 and the mixing vessel ( Rotation may be stopped until 5) is transferred to the anticancer injection preparation device 1.
  • the supply unit 3 is located in the supply transfer area SA after the transfer robot 1200 transfers the pair of drug supply units 20 and the mixing container 5 to the anticancer injection preparation device 1 again. Can rotate.
  • the transport robot 1200 transfers the drug supply unit 20 and the mixing container 5 supplied from the supply unit 1100 to the anticancer injection preparation device 1 or the drug supply unit from the anticancer injection preparation device 1.
  • the transfer robot 1200 is a multi-joint robot, the length of which is extended or shortened through the movement of the articulated joints to hold or grasp items such as chemical supply unit and the mixing vessel.
  • the transport robot 1200 is fixedly installed on the floor and rotated, thereby quickly moving items located in different directions to different locations.
  • the transfer robot 1200 grips the drug supply unit 20 and the empty mixing container 5 containing the anticancer agent supplied from the supply unit 1100 in the supply transfer area SA. It can be transferred to the anticancer injection preparation device 1.
  • the transport robot 1200, the anticancer injection preparation device (1) by holding the drug supply unit 20 containing a mixed container (5) and empty anticancer drug vials prepared by receiving an anticancer injection drug (1) ) May be transferred to the carry-out unit 1300.
  • the transfer robot 1200 may transfer the drug supply unit 20 and the mixing container 5 to the export transfer area (CA, shown in Figure 8).
  • the carry-out transport area CA is an area in which the carry-out part 1300 is installed, and the medicine supply part 20 and the mixing container 5 transferred from the anticancer injection preparation device 1 by the transport robot 1200. Is an area to be placed on the carry-out unit 1300.
  • the transport robot 1200 rotates between the supply unit 1100 and the anticancer injection preparation device 1, and the anticancer injection preparation device 1 and the discharge unit 1300 to supply a medicine supply unit 20 and a mixing container. (5) can be transported. Although not shown, the transfer robot 1200 is incorrectly prescribed by the pharmacist or pharmacist, if the drug supply unit 20 is transferred through the supply unit 1100, incorrectly prescribed drug supply unit 20 in the supply unit 1100 It may be transferred to the carrying out portion 1300 immediately by holding.
  • the transport robot 1200 may be installed to be positioned in the middle of the anticancer injection preparations 1 when a plurality of anticancer injection preparations 1 are installed. That is, the anticancer injection preparation devices 1 may be installed such that the separation distance DL (shown in FIG. 8) spaced apart from the transport robot 1200 is the same. Accordingly, the anticancer injection preparation system 1000 according to the present invention is rotated in a fixed state on the floor even if the transfer robot 1200 does not move to each anticancer injection preparation device 1, thereby providing a Rapidly transfer the drug supply unit 20 and the mixing vessel 5 to the respective anticancer injection preparations 1 or the drug supply unit 20 and from the anticancer injection preparations 1 to the discharge unit 1300.
  • the mixing container 5 can be conveyed quickly.
  • the transfer robot 1200 grips the drug supply unit 20 and the mixing vessel 5 supplied from the supply unit 1100 in the supply transfer area SA, thereby raising and lowering the anticancer injection preparation device 1 ( 80) and the container fixing portion 510 may be provided with the chemical supply unit 20 and the mixing container (5), respectively.
  • the lifting unit 80 may be in a state moved downward to the open inlet of the aseptic preparation 10.
  • the elevating unit 80 may move the chemical supply unit 20 in an upward direction when the chemical supply unit 20 is installed by the transfer robot 1200.
  • the anticancer injection preparation device 1 may prepare an anticancer injection.
  • the drug supply unit 20 may be gripped from the lift unit 80 through the open inlet of the sterile preparation table 10 and then transferred to the discharge unit 1300.
  • the transfer robot 1200 may grip the mixed container 5 containing the anticancer injection agent from the container fixing part 510 and transfer the same to the discharge unit 1300.
  • the carrying out unit 1300 is for carrying out the medicine supply unit 20 and the mixing container 5 in which the anticancer injection agent is transferred from the anticancer injection preparation device 1 by the transfer robot 1200.
  • the carrying out unit 1300 is installed to connect the carrying out area CA and the outside.
  • the carrying out unit 1300 may carry the chemical supply unit 20 and the mixing container 5 transported by the transfer robot 1200 to be carried out to the outside.
  • the carrying out unit 1300 may be a conveyor that rotates between the carrying out area CA and the outside.
  • the carrying out unit 1300 may carry out a pair of chemical supply unit 20 and the mixing vessel (5) made to be sequentially transferred from the transfer robot 1200 to the outside.
  • the mixed container 5 containing the anticancer injection taken out from the carrying out unit 1300 may be moved to another place such as an injection room or a pharmacy by a pharmacist or a pharmacist.
  • the drug supply unit 20 including empty anticancer vials to be taken out from the carrying out unit 1300 may be moved to a washing unit or a recycling unit for reusing the anticancer agent vials.
  • the anticancer injection preparation system 1000 according to the present invention can achieve the following effects.
  • the anticancer injection preparation system 1000 is provided by connecting the supply unit 1100 and the export unit 1300 to the supply transfer area SA and the export transfer area CA, respectively.
  • the anticancer injection preparation device 1 can easily supply and discharge the drug supply unit 20 and the mixing container (5). Accordingly, the anticancer injection preparation system 1000 according to the present invention not only prevents industrial accidents such as musculoskeletal disorders from occurring in the pharmacist or pharmacist, but also contaminates the anticancer injection preparation device 1 for preparing the anticancer injection. It is possible to prevent the substance from penetrating.
  • the anticancer injection preparation system 1000 quickly supplies the medicine supply unit 20 and the mixing container 5 to each of the plurality of anticancer injection preparations 1 by using the transfer robot 1200. Since it can discharge, a large amount of anticancer injections can be prepared quickly.
  • the anticancer injection preparation system 1000 may install a transfer robot in the supply unit 1100 and the export unit 1300, respectively, to fully automate the preparation of the anticancer injection.
  • the anticancer injection preparation system 1000 according to the present invention includes a mixing container 5 as well as a plurality of anticancer drug vials 3 in the drug supply unit 20, so that the transport robot 1200 is a single drug transporting.
  • the supply unit 20 and the mixing container 5 may be supplied to or discharged from the anticancer injection preparation device 1. Accordingly, the anticancer injection preparation system 1000 according to the present invention shortens the time for supplying and discharging the drug supply unit 20 and the mixing container 5 to the anticancer injection preparation device 1, thereby preparing an anticancer injection. The time taken can be further shortened.

Abstract

The present invention relates to an anticancer injection preparation device and, more particularly, to an anticancer injection preparation device and an anticancer injection preparation system comprising the same, wherein predetermined amounts of anticancer agent and infusion can be extracted and used to prepare an anticancer injection through an automated facility while minimizing waste of medications. To this end, there is provided an anticancer injection preparation device comprising: an aseptic preparation table installed inside an aseptic chamber and provided with a preparation chamber in which an anticancer injection is prepared; a medication supply portion installed on the aseptic preparation table, a plurality of anticancer agent vials that contain an anticancer agent being fixed to the medication supply portion such that one is selected from the plurality of anticancer agent vials, thereby supplying the anticancer agent; an injecting device operated such that the same can be aligned with the position of an anticancer agent vial installed on the medication supply portion, the injecting device being configured to extract the anticancer agent from the anticancer agent vial installed on the medication supply portion and to inject the extracted anticancer agent into a place where an infusion is contained; an infusion supply portion installed on the aseptic preparation table so as to supply an infusion that is mixed with the anticancer agent; and a mixing portion provided with a mixing container so as to mix the anticancer agent supplied from the injecting device and the infusion supplied from the infusion supply portion.

Description

항암 주사제 조제장치 및 이를 포함하는 항암 주사제 조제시스템Anticancer injection preparation device and anticancer injection preparation system including the same
본 발명은 항암 주사제 조제장치 및 이를 포함하는 항암 주사제 조제시스템에 관한 것으로서, 보다 구체적으로는 자동화설비를 통해 약품의 낭비를 최소화하고 정량의 항암제와 수액을 추출하여 항암 주사제를 조제할 수 있는 항암 주사제 조제장치 및 이를 포함하는 항암 주사제 조제시스템에 관한 것이다.The present invention relates to an anticancer injection preparation device and an anticancer injection preparation system including the same, and more particularly, an anticancer injection that can prepare an anticancer injection by minimizing waste of drugs through an automated facility and extracting quantitative anticancer drugs and sap. The present invention relates to a preparation device and an anticancer injection preparation system including the same.
일반적으로, 항암 주사제는 항암제와 수액을 일정 비율로 혼합하여 정맥 주사가 가능한 형태로 조제하여 사용되고 있다.In general, anticancer injections are used in a form in which intravenous injection is possible by mixing an anticancer agent with a certain amount of fluid.
이러한 항암 주사제를 조제하기 위해 종래에는 무균조제대에서 약사가 직접 수작업으로 항암제 바이알(vial)로부터 주사기를 이용하여 항암제를 추출하고, 수액과 혼합하는 작업을 통해 이루어졌다.In order to prepare such an anticancer injection, conventionally, a pharmacist at the sterile medicament preparation manual extracts an anticancer agent from an anticancer vial using a syringe and mixes it with the sap.
하지만, 상기와 같은 종래의 항암 주사제 조제방법은 약품을 조제하는 약사가 독성을 갖는 항암제에 직접적으로 노출되어 있어, 이로 인해, 약사가 항암제 접촉으로 인한 각종 질병이 발생할 수 있는 위험성이 존재하고, 반복적인 작업에 의해 근골격계 질환을 유발하게 된다.However, in the conventional method for preparing anticancer drugs, the pharmacist who prepares the drug is directly exposed to the toxic anticancer drug, and thus, there is a risk that the pharmacist may develop various diseases due to the contact with the anticancer drug, and thus, repeatedly. Phosphorus work causes musculoskeletal disorders.
또한, 약사가 수작업으로 항암제와 수액을 추출, 혼합함으로써 정량으로 조제하기 어렵고 정확한 조제 여부를 확인할 수 없어, 수작업에 따른 부정확한 양이 조제되어 항암 주사제를 사용하는 환자의 위험성을 증가시키는 문제가 있다.In addition, the pharmacist extracts and mixes the anticancer agent and the sap manually, and thus it is difficult to quantitatively and accurately determine whether or not the correct preparation is made. Therefore, an incorrect amount is prepared according to the manual operation, thereby increasing the risk of patients using anticancer injections. .
한편, 이러한 약사의 수작업을 통해 항암 주사제를 조제하는 과정에서 약품을 추출하고 주입하는 작업을 주사기펌프를 이용하여 조제하고 있지만, 이는 약사의 작업량을 일부 줄일 수는 있지만 여전히 약사의 판단에 의해 진행되어야 함으로써 약사의 개입이 필요로하게 되고, 또한, 주사기펌프에 연결된 튜브 내에 잔여 약품이 남게 됨으로써 약품이 낭비되는 문제가 있다.On the other hand, while extracting and injecting drugs in the process of preparing anticancer injections through the manual work of the pharmacist using a syringe pump, this may reduce some of the pharmacist's work, but still need to proceed at the discretion of the pharmacist This requires the intervention of a pharmacist, and there is also a problem that the drug is wasted because the remaining drug remains in the tube connected to the syringe pump.
이렇게, 종래에는 항암 주사제를 조제하기 위해 약사의 판단에 따라 수작업으로 항암제와 수액을 추출하고 혼합함으로써 약사의 작업량이 증가하고 정량의 항암 주사제를 조제하는데 어려움이 있어 약품의 신뢰성 떨어지는 문제가 있다.Thus, conventionally, in order to prepare an anticancer injection, the pharmacist extracts and mixes the anticancer agent and the sap manually according to the judgment of the pharmacist, thereby increasing the amount of work of the pharmacist and difficulty in preparing a quantitative anticancer injection.
본 발명은 상기한 종래 기술의 문제점을 해결하기 위해 안출된 것으로서, 자동화설비를 통해 약사의 개입을 줄여 정량의 항암제와 수액을 추출하고 혼합된 항암 주사제의 혼합량을 확인할 수 있도록 하여, 인력을 줄이고 약사의 안전성을 확보하고 정량의 항암 주사제를 조제할 수 있는 항암 주사제 조제장치 및 이를 포함하는 항암 주사제 조제시스템을 제공하는데 그 목적이 있다.The present invention has been made to solve the above problems of the prior art, by reducing the intervention of the pharmacist through an automated facility to extract the quantitative anticancer and sap and to check the mixed amount of the mixed anticancer injection, reducing the manpower and pharmacist It is an object of the present invention to provide an anticancer injection preparation device and an anticancer injection preparation system including the same, which can ensure the safety of the drug and prepare a quantitative anticancer injection.
상기와 같은 목적을 달성하기 위한 본 발명에 따른 항암 주사제 조제장치의 기술적 사상으로는, 무균실 내에 설치되어 항암제 주사제를 조제하는 조제실이 구비된 무균조제대; 상기 무균조제대에 설치되고, 항암제가 수용된 복수개의 항암제 바이알이 고정되어, 복수개의 항암제 바이알 중 어느 하나가 선택되어 항암제를 공급하는 약품공급부; 상기 약품공급부에 설치된 항암제 바이알 위치와 정렬될 수 있도록 작동되고, 약품공급부에 설치된 항암제 바이알로부터 항암제를 추출하여 수액이 수용된 곳으로 추출한 항암제를 주입하기 위한 주사장치; 상기 무균조제대에 설치되고, 항암제와 혼합되는 수액을 공급하기 위한 수액공급부; 및 상기 주사장치로부터 공급받은 항암제와 수액공급부로부터 공급받은 수액을 혼합하기 위해 혼합용기가 구비된 혼합부;를 포함하는 것을 특징으로 한다.Technical concept of the anticancer injection preparation device according to the present invention for achieving the above object is, a sterile preparation stage is provided in the sterile chamber is provided with a preparation chamber for preparing an anticancer injection; A drug supply unit installed in the sterile preparation station and fixed with a plurality of anticancer agent vials containing an anticancer agent, and selecting any one of a plurality of anticancer agent vials to supply an anticancer agent; An injection device operable to be aligned with a location of an anticancer agent vial installed in the drug supply unit, and extracting an anticancer agent from the anticancer agent vial installed in the drug supply unit and injecting the anticancer agent extracted into the place where the sap is accommodated; Sap supply unit is installed in the aseptic preparation, for supplying the sap mixed with the anticancer agent; And a mixing unit provided with a mixing container for mixing the anticancer agent supplied from the injection device with the sap supplied from the infusion supply unit.
또한, 상기 약품공급부 및 상기 주사장치가 결합되고, 상기 약품공급부 및 상기 주사장치를 승강시키기 위한 승강부; 및 상기 무균조제대에 설치되고, 상기 승강부를 지지하기 위한 지지부를 포함하고, 상기 승강부는 상기 지지부에 삽입 가능하도록 상기 지지부에 결합되는 것을 특징으로 한다.In addition, the drug supply unit and the injection device is coupled, the lifting unit for lifting the medicine supply unit and the injection device; And a support part installed on the sterile preparation base and supporting the lifting part, wherein the lifting part is coupled to the support part to be inserted into the support part.
또한, 상기 약품공급부는, 상기 무균조제대에 설치되고, 수직상의 어느 한 축을 중심으로 회전하면서 항암제 바이알이 주사장치와 정렬되어 배치될 수 있도록 설치되는 제1고정부재; 및 상기 무균조제대에 설치되고, 주사장치가 회전하는 축을 중심으로 회전하면서 항암제 바이알이 주사장치와 정렬될 수 있도록 아크(arc) 형상으로 항암제 바이알이 배치될 수 있도록 설치되는 제2고정부재;를 포함하는 것을 특징으로 한다.In addition, the drug supply unit, the first fixing member is installed on the sterile preparation table, the anticancer drug vial is arranged in alignment with the injection device while rotating about any one axis of the vertical; And a second fixing member installed on the sterile preparation table and installed to allow the anticancer drug vial to be arranged in an arc shape so that the anticancer vial can be aligned with the injection device while rotating about the axis of rotation of the injection device. It is characterized by including.
또한, 상기 주사장치는, 상기 약품공급부에서 항암제를 추출하기 위한 주사기; 상기 주사기 하부에 설치되고, 주사기가 약품공급부에 설치된 항암제 바이알의 위치를 향해 회전 가능하게 하는 회전부; 상기 회전부 상부에 설치되고, 주사기가 항암제 바이알의 위치를 향해 직선운동을 하도록 하는 제1리니어; 및 상기 제1리니어 상부에 설치되고, 주사기의 피스톤을 동작시켜 항암제를 추출하거나 주입하도록 하는 제2리니어;를 포함하는 것을 특징으로 한다.In addition, the injection device, a syringe for extracting an anticancer agent from the drug supply; A rotating part installed below the syringe and allowing the syringe to rotate toward a position of an anticancer drug vial installed in the medicine supplying part; A first linear installed at an upper portion of the rotating part to allow the syringe to linearly move toward the position of the anticancer drug vial; And a second linear installed above the first linear to operate the piston of the syringe to extract or inject the anticancer agent.
한편, 상기 수액공급부는, 수액백이 설치되는 수액백 설치부; 상기 수액백 일측에 연결되어 수액백으로부터 추출된 수액이 이송하는 제1연결튜브; 상기 제1연결튜브가 일측에 연결되고, 제1연결튜브를 통해 기설정된 정량만큼 수액백으로부터 추출되도록 펌핑하고 토출하는 정량펌프; 및 상기 정량펌프에서 토출된 수액을 혼합부로 이송하기 위한 제2연결튜브;를 포함하는 것을 특징으로 한다.On the other hand, the sap supply unit, the sap bag installation unit is installed sap bag; A first connection tube connected to one side of the sap bag and transferring the sap extracted from the sap bag; A metering pump connected to one side of the first connecting tube and pumping and discharging the pump to be extracted from the sap bag by a predetermined amount through the first connecting tube; And a second connecting tube for transferring the sap discharged from the metering pump to the mixing unit.
또한, 대량의 항암제를 혼합용기로 주입하기 위해, 대량의 항암제가 저장된 항암제백이 수액백 설치부에 설치되고, 제1연결튜브는 상기 항암제백 일측에 연결되도록 설치되어, 정량펌프의 작동에 의해 대량의 항암제가 제2연결튜브를 통해 혼합용기로 주입될 수 있는 것을 특징으로 한다.In addition, in order to inject a large amount of anticancer agent into the mixing vessel, an anticancer bag in which a large amount of anticancer agent is stored is installed in the sap bag installation unit, and a first connection tube is installed to be connected to one side of the anticancer agent bag, thereby allowing a large amount by operation of a metering pump It is characterized in that the anticancer agent can be injected into the mixing vessel through the second connecting tube.
또한, 상기 혼합부에는, 혼합용기에 수용된 항암제와 수액의 중량을 확인하기 위해 제1전자저울이 더 설치되는 것이 바람직하다.In addition, it is preferable that the first electronic balance is further installed in the mixing part to check the weight of the anticancer agent and the sap contained in the mixing container.
또한, 가루 형태의 항암제가 사용될 경우, 항암제에 수액을 주입하고 수액에 항암제가 용해될 수 있도록 혼합하기 위해 쉐이커가 더 설치되는 것이 바람직하다.In addition, when a powdered anticancer agent is used, it is preferable that a shaker is further installed in order to inject the sap into the anticancer agent and to mix the anticancer agent in the sap.
또한, 항암 주사제 성분이 기재된 처방전 정보를 입력하고, 조제된 항암 주사제의 성분에 대한 정보를 입력하여, 데이터로 저장하기 위한 정보입력부를 더 포함하는 것을 특징으로 한다.The method may further include an information input unit for inputting prescription information describing the anticancer injection component, inputting information about the prepared anticancer injection component, and storing the data as data.
또한, 상기 정보입력부는, 병원전상망 연동을 통해 전달된 처방전 정보와 조제된 항암 주사제의 성분에 대한 정보를 바코드 라벨로 출력하는 바코드 출력기; 처방전 정보와 조제된 항암 주사제의 성분 정보를 읽기 위한 바코드 리더기; 및 상기 바코드 리더기를 통해 입력된 정보를 표시하고 저장하며, 항암 주사제를 조제하는 곳과 병원전산망으로 정보를 전송하기 위한 터치스크린;을 포함하는 것을 특징으로 한다.In addition, the information input unit, a bar code output unit for outputting the information on the prescription information and the components of the prepared anticancer injection drug delivered through the interlocking hospital network; A barcode reader for reading prescription information and ingredient information of the prepared anticancer injection; And a touch screen for displaying and storing the information input through the barcode reader and transmitting the information to the place where the anticancer injection is prepared and the hospital computer network.
본 발명에 따른 항암 주사제 조제시스템은 항암제가 수용된 복수개의 항암제 바이알이 고정되어 복수개의 항암제 바이알 중 어느 하나가 선택되어 항암제를 공급하는 약품공급부, 및 항암제와 수액을 혼합하기 위한 혼합용기를 공급하기 위한 공급부; 상기 공급부로부터 공급되는 약품공급부와 혼합용기를 이용하여 항암 주사제를 조제하기 위한 항암 주사제 조제장치; 상기 공급부로부터 공급되는 약품공급부와 혼합용기를 상기 항암 주사제 조제장치로 이송하거나 상기 항암 주사제 조제장치로부터 약품공급부와 항암 주사제가 수용된 혼합용기를 이송하기 위한 이송로봇; 및 상기 이송로봇에 의해 상기 항암 주사제 조제장치로부터 이송되는 약품공급부와 항암 주사제가 수용된 혼합용기를 반출하기 위한 반출부를 포함하는 것을 특징으로 한다.In the anticancer injection preparation system according to the present invention, a plurality of anticancer drug vials containing an anticancer agent are fixed, and any one of a plurality of anticancer drug vials is selected to supply an anticancer drug, and a mixed container for supplying a anticancer agent and an aqueous solution to mix the sap. Supply unit; An anticancer injection preparation device for preparing an anticancer injection using a medicine supply unit and a mixing container supplied from the supply unit; A transport robot for transporting the drug supply unit and the mixed container supplied from the supply unit to the anticancer injection preparation device or for transporting the mixed container containing the drug supply unit and the anticancer injection drug from the anticancer injection device; And an ejecting unit for carrying out the medicine supplying unit which is transported from the anticancer injection preparation device and the mixed container containing the anticancer injection by the transfer robot.
또한, 본 발명에 따른 항암 주사제 조제시스템은 상기 항암 주사제 조제장치를 복수개 포함하고, 상기 항암 주사제 조제장치들은 각각 상기 이송로봇으로부터 이격된 이격거리가 동일한 위치에 위치하도록 설치되는 것을 특징으로 한다.In addition, the anticancer injection preparation system according to the present invention comprises a plurality of the anticancer injection preparation device, the anticancer injection preparation device is characterized in that each installed so that the separation distance from the transport robot is located at the same position.
상기와 같은 본 발명에 따른 항암 주사제 조제장치 및 이를 포함하는 항암 주사제 조제시스템은 다음과 같은 효과가 있다.The anticancer injection preparation device and the anticancer injection preparation system including the same according to the present invention have the following effects.
주사장치를 통해 약품공급부에 설치된 항암제 바이알로부터 정량의 항암제가 추출되어 혼합부에 설치된 혼합용기에 주입되고, 정량펌프에 의해 수액공급부에 설치된 수액백으로부터 정량의 수액이 추출되어 혼합부의 혼합용기에 주입되어 정량의 항암제와 수액이 혼합된 항암제 주사제가 조제될 수 있게 된다.Through the injection device, the quantitative anticancer agent is extracted from the anticancer agent vial installed in the drug supply unit and injected into the mixing container installed in the mixing unit, and the quantitative sap is extracted from the sap bag installed in the sap supply unit by the metering pump and injected into the mixing container of the mixing unit. Thus, anticancer injectable drugs in which a fixed amount of anticancer agent and sap are mixed can be prepared.
또한, 다량의 항암제가 사용될 경우 정량펌프를 이용하여 항암제를 혼합부의 혼합용기에 주입하고, 가루 형태의 항암제가 사용될 경우 수액을 주입하고 쉐이커를 통해 항암제가 수액에 용해되어 혼합될 수 있게 된다.In addition, when a large amount of anticancer agent is used, the anticancer agent is injected into the mixing portion of the mixing unit by using a metering pump, and when a powdered anticancer agent is used, the sap is injected and the anticancer agent is dissolved in the sap through the shaker and mixed.
이에 따라, 자동화설비를 통해 약사의 개입을 최소화하여 인력을 감소시키고, 항암제와 직접적인 접촉을 줄여 안전성을 확보할 수 있으며, 정량의 항암제와 수액을 혼합함으로써 항암제 주사제 조제의 정확성을 향상시킬 수 있는 효과가 있다.Accordingly, it is possible to reduce the manpower by minimizing the intervention of the pharmacist through the automated facility, to ensure safety by reducing direct contact with the anticancer drug, and to improve the accuracy of the anticancer injection preparation by mixing the quantitative anticancer agent and the sap. There is.
도 1은 본 발명에 따른 항암 주사제 조제장치 구성을 개략적으로 나타낸 전체 구성도.1 is an overall configuration diagram schematically showing the configuration of an anticancer injection preparation device according to the present invention.
도 2는 본 발명에 따른 항암 주사제 조제장치의 요부 구성을 나타낸 도면.Figure 2 is a view showing the main configuration of the anticancer injection preparation device according to the present invention.
도 3은 본 발명의 다른 실시예에 따른 항암 주사제 조제장치의 요부 구성을 나타낸 도면.Figure 3 is a view showing the main components of the anticancer injection preparation device according to another embodiment of the present invention.
도 4는 대량의 항암제가 사용되는 상태를 나타낸 본 발명의 항암 주사제 조제장치의 도면.Figure 4 is a view of the anticancer injection preparation device of the present invention showing a state in which a large amount of anticancer agents are used.
도 5는 본 발명의 또 다른 실시예에 따른 항암 주사제 조제장치의 요부 구성을 나타낸 도면.Figure 5 is a view showing the main components of the anticancer injection preparation device according to another embodiment of the present invention.
도 6 및 도 7은 본 발명의 또 다른 실시예에 따른 항암 주사제 조제장치의 개략적인 작동을 나타낸 작동상태도.6 and 7 is an operating state diagram showing a schematic operation of the anticancer injection preparation device according to another embodiment of the present invention.
도 8은 본 발명에 따른 항암 주사제 조제시스템을 나타낸 개략적인 작동상태도.8 is a schematic operation state diagram showing an anticancer injection preparation system according to the present invention.
본 명세서 및 청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 아니 되며, 발명자는 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다.The terms or words used in this specification and claims are not to be construed as being limited to the common or dictionary meanings, and the inventors can appropriately define the concept of terms in order to explain their invention in the best way. Based on the principle, it should be interpreted as meaning and concept corresponding to the technical idea of the present invention.
이하에서는, 본 발명에 따른 바람직한 실시예를 첨부한 도 1 내지 도 4를 참조하여 상세히 설명한다.Hereinafter, with reference to Figures 1 to 4 attached to a preferred embodiment of the present invention will be described in detail.
도 1은 본 발명에 따른 항암 주사제 조제장치 구성을 개략적으로 나타낸 전체 구성도, 도 2는 본 발명에 따른 항암 주사제 조제장치의 요부 구성을 나타낸 도면, 도 3은 본 발명의 다른 실시예에 따른 항암 주사제 조제장치의 요부 구성을 나타낸 도면, 도 4는 대량의 항암제가 사용되는 상태를 나타낸 본 발명의 항암 주사제 조제장치의 도면이다.1 is an overall configuration diagram schematically showing the configuration of an anticancer injection preparation device according to the present invention, Figure 2 is a view showing the main configuration of the anticancer injection preparation device according to the present invention, Figure 3 is an anticancer according to another embodiment of the present invention Fig. 4 shows the main structure of an injection preparation device. Fig. 4 is a view of the anticancer injection preparation device of the present invention showing a state in which a large amount of anticancer drugs are used.
도 1 및 도 2를 참조하여 설명하면, 본 발명에 따른 항암 주사제 조제장치(1)는 크게, 무균조제대(10), 약품공급부(20), 주사장치(30), 수액공급부(40), 혼합부(50)를 포함하여 구성된다.Referring to Figures 1 and 2, the anticancer injection preparation device 1 according to the present invention is largely, a sterile preparation table 10, the drug supply unit 20, the injection device 30, the fluid supply unit 40, It is comprised including the mixing part 50.
본 발명에 따른 항암 주사제 조제장치(1)는 항암제와 수액을 혼합하여 항암 주사제를 조제하는 데 있어, 약사의 개입을 줄여 정량의 항암제와 수액을 추출하고 혼합하는 작업을 자동화설비를 통해 함으로써 처방에 따른 정확한 항암 주사제를 조제할 수 있도록 한 항암 주사제 조제장치에 관한 것이다.In the anticancer injection preparation device 1 according to the present invention, in the preparation of anticancer injections by mixing the anticancer drugs and the sap, by reducing the intervention of the pharmacist to extract and mix the quantitative anticancer drugs and the sap through an automated facility to prescribe The present invention relates to an anticancer injection preparation device capable of preparing an accurate anticancer injection.
먼저, 무균조제대(10)는 항암 주사제를 조제하기 위한 공간을 제공한다.First, the sterile preparation table 10 provides a space for preparing an anticancer injection.
상기 무균조제대(10)는 약사 또는 관리자가 조제 작업을 수행하기 용이하도록 지면으로부터 일정 높이가 띄워질 수 있도록 지면에는 지지부(110)가 설치되고, 상기 지지부(110) 상부에는 조제 설비 및 조제작업을 수행하기 위한 공간이 구비된 조제실(120)이 설치된다.The sterile dispensing table 10 is a support 110 is installed on the ground so that a certain height can be floated from the ground to facilitate the pharmacist or manager, the preparation unit and the preparation work on the support 110 Preparation room 120 is provided with a space for performing this.
이러한, 상기 무균조제대(10)는 기본적으로 무균실 내에 설치되는 것을 원칙으로 하고, 조제실(120) 당 약사가 1명 또는 2명 정도가 배치되어 항암 주사제 조제작업을 수행할 수 있게 된다.In principle, the sterile preparation table 10 is basically installed in a sterile chamber, and one or two pharmacists per dispensing room 120 may be arranged to perform anticancer injection preparation.
또한, 상기 조제실(120)은 정면에서 봤을 때 일부가 개방된 형태로 이루어지고, 내부에는 확장된 공간이 구비될 수 있으며, 장비 및 약품을 놓기 위한 테이블(121)이 구비되어, 개방된 부분을 통해 약사가 장비 또는 약품을 취급하여 조제작업을 수행할 수 있다.In addition, the dispensing room 120 is formed in the form of a part when viewed from the front, and may be provided with an extended space therein, the table 121 for placing equipment and drugs is provided, This allows the pharmacist to handle the equipment or drug and perform the preparation.
한편, 상기 지지부(110)에는 이동성을 향상시키기 위해 지면과 닿는 부분에 이동수단(예, 바퀴) 등이 더 설치될 수도 있다.On the other hand, the support 110 may be further provided with a moving means (for example, wheels) and the like in contact with the ground to improve mobility.
다음으로, 양품공급부(20)는 항암제를 공급하기 위한 부분이다.Next, the non-defective supply unit 20 is a part for supplying the anticancer agent.
상기 약품공급부(20)는 상기 무균조제대(10)의 조제실(120)에 설치된다.The drug supply unit 20 is installed in the preparation chamber 120 of the sterile preparation table 10.
또한, 상기 약품공급부(20)는 별도의 블록 등의 구조물에 부착되어 설치될 수 있으며, 블록의 형태는 한정하지 않는다.In addition, the drug supply unit 20 may be attached to a structure such as a separate block is installed, the shape of the block is not limited.
여기서, 상기 약품공급부(20)는 항암 주사제를 조제하는 데 있어, 항암제와 수액 중 항암제를 공급하기 위한 부분으로, 다량의 항암제를 연속해서 공급하기 위해 복수개의 항암제 바이알(vial)(3)이 설치되는 부분이다.Here, the drug supply unit 20 is a part for supplying the anticancer drug and the sap in the preparation of anticancer injections, a plurality of anticancer vials (vial) (3) is installed to continuously supply a large amount of anticancer drugs It is a part.
상기 항암제 바이알(3)은 수액이 첨가되지 않은 순수 항암제 약품이 저장된 것으로, 유리병에 주입된 형태로 입구는 주사 바늘을 삽입할 수 있도록 형성된다.The anticancer drug vial 3 is stored as a pure anticancer drug without the addition of sap, and the inlet is formed to insert the injection needle in the form of a glass bottle.
이러한 상기 약품공급부(20)는 항암제 바이알(3)이 복수개가 설치되어 연속해서 항암제 추출작업을 수행할 수 있도록 구성된다.The drug supply unit 20 is configured such that a plurality of anticancer drug vials 3 are installed to continuously perform the anticancer drug extraction.
이때, 복수개의 항암제 바이알(3) 중 어느 하나가 선택되어 항암제를 공급할 수 있도록 형성될 수 있다.At this time, any one of the plurality of anticancer agent vials 3 may be selected to be formed to supply the anticancer agent.
상기 약품공급부(20)는 경우에 따라 항암제 바이알(3) 외에 다른 형태의 용기에 저장된 항암제를 공급할 수도 있다.The drug supply unit 20 may supply an anticancer agent stored in a container of another type in addition to the anticancer agent vial 3 in some cases.
한편, 상기 약품공급부(20)는 그 형태에 따라, 제1고정부재(210) 및 제2고정부재(220)를 포함하여 구성된다.On the other hand, the drug supply unit 20 is configured to include a first fixing member 210 and the second fixing member 220 according to its form.
먼저, 상기 제1고정부재(210)는 상기 조제실(120)의 테이블(121) 상부에 배치되어 정면에서 봤을 때 수직상으로 어느 한 축을 중심으로 회전할 수 있도록 회전축(211)이 설치되고, 상기 회전축(211)에는 항암제 바이알(3)이 설치되는 지그판(212)이 설치된다.First, the first fixing member 210 is disposed above the table 121 of the preparation chamber 120 and a rotation shaft 211 is installed to rotate about any axis vertically when viewed from the front, and the The rotating shaft 211 is provided with a jig plate 212 in which the anticancer agent vial 3 is installed.
또한, 상기 지그판(212)의 테두리 부분에는 복수개의 항암제 바이알(3)이 배치되어 고정될 수 있도록 제1클램프(212a)가 설치된다.In addition, a first clamp 212a is installed at the edge of the jig plate 212 so that a plurality of anticancer vials 3 are disposed and fixed.
즉, 상기 회전축(211)이 수직상에서 회전될 수 있도록 형성되고, 회전축(211) 상부에 원형 또는 사각형의 판 형태의 지그판(212)이 설치되며, 지그판(212)에 설치된 복수개의 제1클램프(212a)에 항암제 바이알(3)이 설치되어, 지그판(212)이 회전됨에 따라 특정 위치로 항암제 바이알(3)이 정렬 배치될 수 있게 된다.That is, the rotary shaft 211 is formed so as to be rotated in the vertical phase, the jig plate 212 in the form of a circular or square plate is installed on the rotary shaft 211, a plurality of first installed on the jig plate 212 The anticancer agent vial 3 is installed in the clamp 212a so that the anticancer agent vial 3 can be arranged in a specific position as the jig plate 212 is rotated.
상기 항암제 바이알(3)이 정렬되는 위치는 후술하는 주사장치(30)의 위치와 일치되는 위치를 말한다.The position at which the anticancer agent vial 3 is aligned refers to a position coinciding with the position of the injection device 30 described later.
도 3을 참조하여 설명하면, 상기 제2고정부재(220)는 상기 조제실(120)의 테이블(121) 상부에 배치되어 정면에서 봤을 때 복수개의 항암제 바이알(3)이 아크(arc) 형상으로 배치될 수 있도록 형성된다.Referring to FIG. 3, the second fixing member 220 is disposed above the table 121 of the preparation chamber 120 such that a plurality of anticancer vials 3 are arranged in an arc shape when viewed from the front. It is formed to be.
먼저, 상기 제2고정부재(220)는 크게, 동력부(221), 아크부재(222), 제2클램프(222a)을 포함한다.First, the second fixing member 220 includes a power unit 221, an arc member 222, and a second clamp 222a.
상기 동력부(221)는 아크부재(222) 하부, 즉, 정면에서 봤을 때 아크부재(222) 안쪽에 배치되도록 설치되어 아크부재(222)를 좌측 또는 우측으로 이동시키기 위한 부분이다.The power unit 221 is installed below the arc member 222, that is, to be disposed inside the arc member 222 when viewed from the front to move the arc member 222 to the left or right.
또한, 아크부재(222)는 아크(arc) 형상의 띠 형태로 형성되어 동력부(221)에 의해 동력부(221) 상에서 좌측 또는 우측으로 이동하고, 상기 아크부재(222)에는 일정 간격마다 항암제 바이알(3)이 고정될 수 있도록 복수개의 제2클램프(222a)가 설치된다.In addition, the arc member 222 is formed in the shape of an arc strip (arc) is moved to the left or right on the power unit 221 by the power unit 221, the arc member 222 at a predetermined interval of the anticancer agent A plurality of second clamps 222a are installed to fix the vials 3.
즉, 동력부(221)에서 동력이 발생하면 아크부재(222)는 좌측 또는 우측으로 회전하 듯 이동하고 제2클램프(222a)에 고정된 항암제 바이알(3)은 기울어진 상태에서 수직으로 곧게 세워진 상태로 배치될 수 있게 된다.That is, when power is generated in the power unit 221, the arc member 222 moves to rotate left or right, and the anticancer agent vial 3 fixed to the second clamp 222a is erected vertically in an inclined state. It can be placed in a state.
이는, 후술하는 주사장치(30)와 일렬로 정렬되기 위함이다.This is to align in line with the scanning device 30 to be described later.
따라서, 상기 제2고정부재(220)는 회전하는 기준 위치가 주사장치(30)와 동일한 위치일 수 있다.Therefore, the reference position of the second fixing member 220 may be the same position as the injection device 30.
다음으로, 주사장치(30)는 항암제 바이알(30)로부터 항암제를 추출하거나 수액이 수용된 곳으로 주입하기 위한 역할을 한다.Next, the injection device 30 serves to extract the anticancer agent from the anticancer agent vial 30 or inject into the place where the fluid is accommodated.
상기 주사장치(30)는 약품공급부(20)의 항암제 바이알(3) 위치와 정렬될 수 있도록 조제실(120)의 테이블(121) 상부에 설치된다.The injection device 30 is installed above the table 121 of the preparation chamber 120 so that the injection device 30 can be aligned with the anticancer drug vial 3 position of the drug supply unit 20.
즉, 약품공급부(20)의 제1고정부재(210) 및 제2고정부재(220) 하부에 설치되어 제2고정부재(210) 및 제2고정부재(220)의 동작에 따라 항암제 바이알(30)의 배치되는 위치에 대응할 수 있도록 설치된다.That is, the anticancer agent vial 30 is installed under the first fixing member 210 and the second fixing member 220 of the chemical supply unit 20 according to the operation of the second fixing member 210 and the second fixing member 220. It is installed so as to correspond to the position of the arrangement.
상기 주사장치(30)는 항암제를 추출하고 주입하기 위한 주사기(310), 상기 주사기(310)가 약품공급부(20) 방향으로 회전 가능하게 하는 회전부(320), 상기 주사기(310)가 약품공급부(20) 방향으로 직선운동을 하도록 하는 제1리니어(330), 상기 주사기(310)의 피스톤 동작을 위해 직선운동하는 제2리니어(340)를 포함하여 구성된다.The injection device 30 is a syringe 310 for extracting and injecting an anticancer agent, a rotating part 320 to enable the syringe 310 to rotate in the direction of the drug supply unit 20, the syringe 310 is a drug supply unit ( The first linear 330 to perform a linear movement in the 20) direction, and the second linear 340 to linearly move for the piston operation of the syringe 310.
먼저, 상기 주사기(310)는 주사기 바늘이 항암제 바이알(3)에 꼽힌 상태에서 피스톤운동을 통해 항암제 바이알(3)로부터 항암제를 추출하거나 수액이 위치된 곳으로 주입할 수 있게 된다.First, the syringe 310 is able to extract the anticancer agent from the anticancer agent vial 3 or inject the fluid into the position through the piston movement in the state in which the syringe needle is plugged into the anticancer agent vial 3.
또한, 상기 회전부(320)는 주사기(310) 하부에 설치되어, 약품공급부(20)에 설치된 항암제 바이알(3)의 위치를 향해 주사기(310)가 위치될 수 있도록 회전시키기 위한 부분이다.In addition, the rotating part 320 is installed under the syringe 310 to rotate the syringe 310 to be positioned toward the position of the anticancer drug vial 3 installed in the medicine supply part 20.
따라서, 상기 회전부(320)는 정면에서 봤을 때 수평배치되어 회전되도록 설치된다.Therefore, the rotating part 320 is installed to rotate horizontally when viewed from the front.
또한, 상기 제1리니어(330)는 회전부(320) 상부에 설치되어, 제1고정부재(210) 또는 제2고정부재(22)에 설치된 항암제 바이알(3)의 위치까지 주사기(310)가 위치될 수 있도록 직선운동을 하는 부분이다.In addition, the first linear 330 is installed above the rotating part 320, the syringe 310 is positioned to the position of the anticancer agent vial 3 installed in the first fixing member 210 or the second fixing member 22. It is a part that makes a linear motion so that it can be.
상기 제1리니어(330)는 일반적인 LM가이드 구동방식으로 직선운동 동작이 구현될 수 있다.The first linear 330 may be a linear motion operation by a general LM guide driving method.
한편, 상기 제2리니어(340)는 제1리니어(330) 상부에 설치되고 주사기(310)의 피스톤에 부착 설치되어 주사기(310)의 피스톤을 동작시켜 주사기(310) 바늘이 항암제 바이알(3)의 입구로 삽입되도록 하여 항암제를 추출할 수 있게 된다.Meanwhile, the second linear 340 is installed on the first linear 330 and attached to the piston of the syringe 310 to operate the piston of the syringe 310 so that the needle of the syringe 310 is the anticancer vial 3. It is inserted into the entrance of the anticancer drug can be extracted.
또한, 상기 제2리니어(340)는 회전부(320)를 통해 주사기(310)가 회전하여 후술하는 수액과 혼합되는 혼합부(50) 위치로 배치된 후 항암제를 혼합부(50)로 주입할 수 있도록 직선운동을 구현한다.In addition, the second linear 340 may be injected into the mixing unit 50 after the syringe 310 is disposed in the mixing unit 50 position where the syringe 310 is rotated and mixed with the sap to be described later through the rotating unit 320. Implement a linear motion so that
즉, 상기 주사기(310)는 회전부(320)에 의해 항암제 바이알(3) 또는 혼합부(50) 위치로 회전할 수 있고, 제1리니어(330)를 통해 항암제 바이알(3) 또는 혼합부(50) 위치까지 접근한 후 제2리니어(330)를 통해 항암제를 추출하고 주입하는 동작이 구현될 수 있게 된다.That is, the syringe 310 may rotate to the anticancer agent vial 3 or the mixing unit 50 position by the rotating unit 320, the anticancer agent vial 3 or the mixing unit 50 through the first linear 330. After approaching to the) position, the operation of extracting and injecting the anticancer agent through the second linear 330 may be implemented.
다음으로, 수액공급부(40)는 상기 주사기(310)에 의해 추출된 항암제와 혼합되어 항암 주사제로 조제되기 위해 필요한 수액을 공급하기 위한 부분이다.Next, the fluid supply unit 40 is a portion for supplying the fluid required to be mixed with the anticancer agent extracted by the syringe 310 to be prepared as an anticancer injection.
상기 수액공급부(40)는 크게, 수액백 설치부(410), 제1연결튜브(420), 정량펌프(430), 제2연결튜브(44)를 포함한다.The infusion supply unit 40 includes a sap bag installation unit 410, a first connection tube 420, a metering pump 430, and a second connection tube 44.
상기 수액백 설치부(410)는 무균조제대(10)의 조제실(120) 상부에 설치된다.The infusion bag installation unit 410 is installed on the preparation chamber 120 of the sterile preparation table 10.
상기 수액백 설치부(410)는 수액을 원활하게 공급하기 위해 수액이 저장된 수액백(2)이 수직으로 세워진 상태로 설치될 수 있도록 형성된다.The sap bag installation unit 410 is formed so that the sap bag (2) in which the sap is stored to be installed in a vertical position in order to smoothly supply the sap.
예컨대, 수액백 설치부(410)는 수액백(2)에 고리가 형성될 수 있고, 고리를 통해 수액백(2)이 용이하게 고정될 수 있도록 수평상으로 막대 형태로 형성될 수도 있다.For example, the sap bag installation unit 410 may be formed in a ring on the sap bag (2), it may be formed in a bar shape horizontally so that the sap bag (2) can be easily fixed through the ring.
하지만, 상기 수액백 설치부(410)는 형태를 한정하지는 않으며 수액백(2)이 조제실(120) 내에 수직상으로 배치되도록 설치할 수 있는 형태이면 여러 형태로 구성될 수도 있다.However, the infusion bag installation unit 410 is not limited to the form and may be configured in various forms as long as the infusion bag 2 can be installed so as to be disposed vertically in the preparation chamber 120.
한편, 상기 제1연결튜브(420)는 수액백(2) 일측에 연결되어 수액백(2)으로부터 추출된 수액이 이송하는 부분이다.On the other hand, the first connection tube 420 is connected to one side of the sap bag (2) is the portion to which the sap extracted from the sap bag (2) is transferred.
또한, 상기 정량펌프(430)는 상기 제1연결튜브(420)가 일측에 연결되고, 제1연결튜브(420)를 통해 기설정된 정량만큼 수액백(2)으로부터 수액이 추출되도록 펌핑하고 토출하는 역할을 한다.In addition, the metering pump 430 is connected to one side of the first connecting tube 420, the pumping and discharging so that the sap is extracted from the sap bag 2 by a predetermined amount through the first connecting tube 420 Play a role.
또한, 상기 제2연결튜브(440)는 상기 정량펌프(430)에서 토출된 수액을 혼합부(50)로 이송하기 위한 부분이다.In addition, the second connection tube 440 is a portion for transferring the sap discharged from the metering pump 430 to the mixing unit 50.
즉, 상기 수액백 설치부(410)에 설치된 수액백(2)에 제1연결튜브(420)가 연결되고, 상기 제1연결튜브(420) 일측이 정량펌프(430)로 연결되며, 정량펌프(430) 타측에는 제2연결튜브(440) 일측이 연결되고 타측은 혼합부(50)에 연결되도록 설치되어, 정량펌프(430)가 작동하면 수액백(2)에 저장된 수액은 제1연결튜브(420)를 타고 정량펌프(430)로 유입되고 정량펌프(430)의 펌핑에 의해 수액이 제2연결튜브(440)를 통해 혼합부(50)로 이송될 수 있게 된다.That is, a first connecting tube 420 is connected to the sap bag 2 installed in the sap bag installation unit 410, and one side of the first connecting tube 420 is connected to the metering pump 430. One side of the second connection tube 440 is connected to the other side and the other side is installed to be connected to the mixing unit 50. When the quantitative pump 430 operates, the sap stored in the sap bag 2 is the first connection tube. The 420 is introduced into the metering pump 430 and the sap can be transferred to the mixing unit 50 through the second connecting tube 440 by the pumping of the metering pump 430.
이에 따라, 정량펌프(430)에 의해 정량의 수액이 혼합부(50)로 주입될 수 있게 되는 것이다.Accordingly, the quantitative sap can be injected into the mixing unit 50 by the quantitative pump 430.
또한, 상기 제1연결튜브(420) 및 제2연결튜브(440) 끝단에는 수액백(2) 등과 연결되기 위한 커넥터가 설치되는 것이 바람직하다.In addition, the end of the first connecting tube 420 and the second connecting tube 440 is preferably a connector for connecting to the sap bag (2) and the like.
여기서 상기 정량펌프(430)는 연속적으로 흐르는 액체에 아주 적은 양의 물질을 정확하게 제어하여 넣을 때에 쓰는 플런저(plunger) 타입의 펌프를 말하며, 일측에서 튜브관을 타고 유입되는 유체를 타측의 튜브관으로 펌핑하여 이송하기 위한 장치로서, 일반적으로 튜빙펌프라고도 한다.Here, the metering pump 430 refers to a plunger-type pump used for accurately controlling a very small amount of material into a continuously flowing liquid, and the fluid flowing through the tube tube from one side to the other tube tube An apparatus for pumping and conveying, generally referred to as a tubing pump.
다음으로, 혼합부(50)는 항암제와 수액이 모아 혼합하기 위한 부분이다.Next, the mixing unit 50 is a portion for mixing and mixing the anticancer agent and the sap.
상기 혼합부(50)는 무균조제대(10)의 조제실(120) 일측에 설치되고, 상기 주사장치(30)로부터 공급받은 항암제와 수액공급부(40)로부터 공급받은 수액을 혼합하기 위해 부분으로, 항암제와 수액을 수용하기 위한 혼합용기(5)가 구비된다.The mixing unit 50 is installed at one side of the preparation chamber 120 of the sterile preparation table 10, and is a portion for mixing the anticancer agent supplied from the injection device 30 and the sap supplied from the sap supply unit 40, The mixing container 5 for accommodating the anticancer agent and the sap is provided.
이러한 상기 혼합부(50)에는 혼합용기(50)를 고정하기 위해 용기고정부(510)가 설치되고, 혼합용기(5)에 수용된 항암제와 수액의 중량을 확인하기 위해 제1전자저울(520)이 더 설치되는 것이 바람직하다.The mixing unit 50 is provided with a container fixing part 510 to fix the mixing container 50, the first electronic balance 520 to check the weight of the anticancer agent and the sap contained in the mixing container (5) It is preferable to install this further.
즉, 혼합부(50)에 설치되는 혼합용기(5)는 바람직하게 수평으로 누워진 형태로 용기고정부(510)에 의해 고정될 수 있고, 혼합용기(5)에 주입되는 항암제 및 수액의 주입량에 따른 중량의 변화를 제1전자저울(520)을 통해 확인할 수 있게 된다.That is, the mixing container 5 installed in the mixing part 50 may be fixed by the container fixing part 510 in a preferably laid horizontal shape, and the injection amount of the anticancer agent and the sap injected into the mixing container 5. The change in weight can be confirmed through the first electronic balance 520.
이와 같이, 상기 주사장치(30)의 주사기(310)를 통해 약품공급부(20)에서 항암제를 추출하고 회전부(320)에 의해 혼합부(50)의 혼합용기(5)로 항암제가 주입되고, 수액공급부(40)를 통해 정량의 수액을 혼합부(50)의 혼합용기(5)로 주입한 후, 항암제와 수액이 혼합용기(5)에 모여 혼합됨으로써 항암 주사제가 조제될 수 있게 된다.As such, the anticancer agent is extracted from the drug supply unit 20 through the syringe 310 of the injection device 30, and the anticancer agent is injected into the mixing container 5 of the mixing unit 50 by the rotating unit 320, After injecting the quantitative amount of the sap into the mixing container 5 of the mixing part 50 through the supply part 40, the anticancer agent and the sap are collected and mixed in the mixing container 5 so that the anticancer injection can be prepared.
한편, 항암제 바이알(3)에 저장된 항암제가 가루형태로 공급될 경우, 항암제 바이알(3)에 저장된 항암제에 수액을 주입하고 수액에 항암제가 용해될 수 있도록 혼합하기 위해 쉐이커(60)가 더 설치되는 것이 바람직하다.On the other hand, when the anticancer agent stored in the anticancer agent vial 3 is supplied in powder form, the shaker 60 is further installed to inject the sap into the anticancer agent stored in the anticancer agent vial 3 and to mix the anticancer agent in the sap solution. It is preferable.
상기 쉐이커(60)는 가루형태의 항암제와 수액이 용이하게 용해되어 혼합될 수 있도록 하는 역할을 한다.The shaker 60 serves to make the powdered anticancer agent and the sap easily dissolved and mixed.
이때, 상기 쉐이커(60)가 동작되기 이전에 수액의 정량 주입 여부를 확인하기 위해 제2전자저울(610)이 더 설치될 수 있으며, 상기 제2전자저울(610)을 통해 정량의 수액이 주입된 것을 확인한 후 항암제와 수액을 혼합하기 위해 쉐이커(60)가 작동하게 된다.In this case, before the shaker 60 is operated, a second electronic balance 610 may be further installed to check whether the fluid is quantified, and the quantitative fluid is injected through the second electronic scale 610. After confirming that the shaker 60 is operated to mix the anticancer agent and the sap.
한편, 상기 설명한 항암제에 있어, 항암제 바이알(3) 외에 대량의 항암제를 사용하여 대용량의 항암 주사제를 조제하고자 할 경우에는, 대량의 항암제를 혼합용기로 주입하기 위해, 대량의 항암제가 저장된 항암제백(4)이 수액백 설치부(410)에 설치되고, 제1연결튜브(420)는 상기 항암제백(4) 일측에 연결되도록 설치되어, 정량펌프(430)의 작동에 의해 대량의 항암제가 제2연결튜브(440)를 통해 혼합용기(5)로 주입될 수도 있다.On the other hand, in the anticancer agent described above, when a large amount of anticancer injections are to be prepared using a large amount of anticancer drugs in addition to the anticancer agent vial (3), in order to inject a large amount of anticancer drugs into a mixed container, 4) is installed in the sap bag installation unit 410, the first connecting tube 420 is installed to be connected to one side of the anticancer agent bag (4), a large amount of anticancer agent by the operation of the metering pump 430 It may be injected into the mixing vessel (5) through the connecting tube (440).
이 경우, 약품공급부(20)에 설치된 항암제 바이알(3)을 이용하지 않고, 대용량의 항암제가 수용된 항암제백(4)이 설치되어, 정량펌프(430)을 통해 항암제를 혼합용기(5)로 주입하게 되는 것이다.In this case, without using the anticancer agent vial 3 installed in the drug supply unit 20, an anticancer agent bag 4 containing a large amount of anticancer agent is installed, and the anticancer agent is injected into the mixing container 5 through the metering pump 430. Will be done.
한편, 처방전 정보 및 항암 주사제 조제 정보를 데이터로 저장하기 위한 정보입력부(70)가 더 설치될 수도 있다.Meanwhile, an information input unit 70 may be further provided to store prescription information and anticancer drug preparation information as data.
상기 정보입력부(70)는 크게, 바코드 출력기(710), 바코드 리더기(720), 터치스크린(730)을 포함한다.The information input unit 70 largely includes a barcode printer 710, a barcode reader 720, and a touch screen 730.
상기 정보입력부(70)는 병원전산망으로부터 항암 주사제 성분이 기재된 처방전 정보를 전달받아 입력하고, 조제된 항암 주사제의 성분에 대한 정보를 입력하여, 데이터로 저장하기 위한 부분이다.The information input unit 70 is a part for receiving and inputting prescription information describing an anticancer injection drug component from a hospital computer network, and inputting information on the components of the prepared anticancer injection drug and storing it as data.
상기 바코드 출력기(710)는 병원전상망 연동을 통해 전달된 처방전 정보와 조제된 항암 주사제의 성분에 대한 정보를 바코드 라벨로 출력하는 부분이다.The barcode output unit 710 is a part for outputting the prescription information and the information on the components of the prepared anticancer injection drug delivered through the hospital network interlock as a barcode label.
또한, 상기 바코드 리더기(720)는 처방전 정보와 조제된 항암 주사제의 성분 정보를 읽어 데이터로 저장하기 위한 부분이다.In addition, the barcode reader 720 is a portion for reading the prescription information and the component information of the anticancer injection drug prepared as data to store.
또한, 터치스크린(730)은 상기 바코드 리더기(720)를 통해 입력된 정보를 표시하고 저장하며, 항암 주사제를 조제하는 곳과 병원전산망으로 정보를 전송하기 위한 역할을 한다.In addition, the touch screen 730 displays and stores the information input through the bar code reader 720, and serves to transmit the information to the place where the anti-cancer injection drug and hospital hospital network.
이때, 상기 터치스크린(730)은 정보를 표시하는 디스플레이 기능 외에 정보처리 및 연산장치를 포함하는 것으로, 예컨대, 일체형PC 형태일 수 있다.In this case, the touch screen 730 includes an information processing and computing device in addition to a display function of displaying information, and may be, for example, in the form of an integrated PC.
따라서, 상기 바코드 리더기(720)와 바코드 출력기(710)는 터치스크린(730)의 조작을 통해 입출력하는 장치로서 이용될 수 있도록 구성된다.Therefore, the bar code reader 720 and the bar code output device 710 are configured to be used as a device for inputting and outputting through manipulation of the touch screen 730.
즉, 외래진료 및 병동에서 환자의 처방전이 발급되면 병원전산망을 통해 처방전 정보가 터치스크린(730)으로 전달되어 표시되고, 약사는 처방전 정보를 확인한 후 바코드 출력기(710)를 통해 처방전에 대한 기록이 기재된 바코드 라벨을 출력하여 혼합용기(5)에 부착한다.That is, when the patient's prescription is issued in the outpatient care and wards, the prescription information is displayed and displayed on the touch screen 730 through the hospital computer network, and the pharmacist checks the prescription information and then records the prescription through the barcode printer 710. The bar code label described is output and attached to the mixing container (5).
또한, 항암제와 수액이 혼합된 혼합용기(5)에는 항암 주사제 조제 성분에 대한 결과 정보가 터치스크린(730)에 표시되고 약사는 상기 항암 주사제 조제 성분에 대한 정보를 바코드로 출력한 후 혼합용기(5)에 부착한다.In addition, in the mixed container (5) in which the anticancer agent and the sap are mixed, the result information of the anticancer drug preparation component is displayed on the touch screen 730, and the pharmacist outputs the information of the anticancer drug preparation component as a barcode and then the mixed container ( 5) Attach to.
그 다음, 바코드 리더기(720)를 통해 항암 주사제 조제 성분에 대한 정보를 바코드 읽어 터치스크린(730)에 데이터를 저장한다.Next, the barcode reader 720 reads information about the anticancer drug preparation component and stores the data on the touch screen 730.
이를 통해, 약사가 처방전 정보 및 항암 주사제 조제 정보를 비교하여 확인할 수 있고, 각 환자별 항암 주사제 조제 이력을 데이터로 저장할 수 있게 된다.Through this, the pharmacist can check and compare the prescription information and the anticancer injection preparation information, and can store the history of the anticancer injection preparation for each patient as data.
이처럼 상기 정보입력부(70)는 환자 개인에 대한 처방전 정보와 항암 주사제 조제 정보를 바코드로 입력하고 출력하여 데이터로 저장함으로써 변원전산망과 연동하여 환자에 대한 정확한 처방 및 조제가 이루어질 수 있도록 할 수 있게 된다.As such, the information input unit 70 may input and output the prescription information and the anticancer injection preparation information for the patient as a bar code, and output the data as a bar code so that accurate prescription and preparation for the patient may be performed in connection with the computer network. .
한편, 무균조제대(10)에 설치되는 약품공급부(20), 주사장치(30), 수액공급부(40), 혼합부(50), 쉐이커(60), 정보입력부(70)의 설치 위치는 한정하지는 않으며 유동적으로 설치될 수 있음을 밝히며, 주사장치(30)에 대해 약품공급부(20) 및 혼합부(50)가 연동하여 동작할 수 있는 위치이면 특정 위치를 한정하지 않는다.On the other hand, the installation position of the chemical supply unit 20, the injection device 30, the fluid supply unit 40, the mixing unit 50, the shaker 60, the information input unit 70 is installed in the aseptic preparation table 10 is limited It does not do but reveals that the fluid can be installed, and the injection device 30 is not limited to a specific position as long as the drug supply unit 20 and the mixing unit 50 can operate in conjunction.
이하에서는 도 1 내지 도 4를 참조하여 상기 설명한 항암 주사제 조제장치의 작용에 대하여 설명한다.Hereinafter, the operation of the anticancer injection preparation device described above will be described with reference to FIGS. 1 to 4.
먼저, 외래진료 및 병동에서 환자에 대한 처방전이 발급되면 병원전산망을 통해 환자의 처방전 정보가 터치스크린(730)으로 전달되어 표시된다.First, when a prescription for a patient is issued in an outpatient clinic and a ward, the patient's prescription information is transmitted to and displayed on the touch screen 730 through the hospital computer network.
그 다음, 약사는 터치스크린(730)에 표시된 정보를 확인한 후 처방전 정보를 바코드로 생성하여 바코드 출력기(710)를 통해 바코드 라벨을 출력한 후 항암 주사제가 조제되기 위한 혼합용기(5)에 부착하고, 바코드 리더기(720)를 통해 바코드를 읽어 데이터로 저장한다.Next, the pharmacist checks the information displayed on the touch screen 730, generates prescription information as a barcode, outputs the barcode label through the barcode printer 710, and attaches it to the mixed container 5 for the anticancer injection. The barcode is read through the barcode reader 720 and stored as data.
그 다음, 약사는 혼합용기(5)를 혼합부(50)의 용기고정부(510)에 고정시키고, 터치스크린(730)을 통해 처방전에 따른 항암제 및 수액 추출 및 주입 데이터를 약품공급부(20)와 주사장치(30), 수액공급부(40) 등으로 전송하여 작동에 대한 세팅이 이루어지도록 한다.Next, the pharmacist fixes the mixing container 5 to the container fixing part 510 of the mixing part 50, and the anticancer and sap extraction and infusion data according to the prescription through the touch screen 730 drug supply unit 20 And to the injection device 30, the fluid supply unit 40 and the like to make the setting for the operation.
이때, 약사는 처방전 입력 및 커넥터 등을 부착하는 작업과 약품을 설치하는 작업을 수행한다.At this time, the pharmacist performs a task of attaching a prescription input and connector, and installing a medicine.
이렇게 환자에 대한 처방전에 따라 항암 주사제 조제 성분이 결정되고 장비 세팅이 이루어지면, 먼저 약품공급부(20)에서 항암제를 공급한다.When the anticancer injection preparation component is determined according to the prescription for the patient and the equipment setting is made, the drug supply unit 20 first supplies the anticancer drug.
한편, 상기 약품공급부(20)에서 제1고정부재(210)가 사용될 경우, 회전축(211)을 중심으로 지그판(212)이 회전하여 항암제 바이알(3)이 주사장치(30)의 주사기(310) 위치와 일렬로 배치되어 정렬될 수 있도록 작동된다.On the other hand, when the first fixing member 210 is used in the medicine supply unit 20, the jig plate 212 is rotated around the rotating shaft 211, the anticancer vial 3 is the syringe 310 of the injection device 30 ) So that it can be arranged in line with the position.
이때, 주사기(310)는 회전부(320)에 의해 항암제 바이알(3) 위치를 향해 회전하고, 제1리니어(330)에 의해 항암제 바이알(3) 위치로 전진한 후, 제2리니어(340)를 통해 주사기(310) 피스톤이 동작하여 항암제 바이알(3)에 주사기(310) 바늘이 삽입하여 항암제를 추출한다.At this time, the syringe 310 is rotated toward the anticancer agent vial 3 position by the rotating unit 320, and advanced to the anticancer agent vial 3 position by the first linear 330, and then the second linear 340 is moved. The syringe 310 is operated through the needle to insert the syringe 310 into the anticancer agent vial 3 to extract the anticancer agent.
그 다음, 제2리니어(340)가 후진 동작하여 항암제 바이알(3)로부터 주사기(310) 바늘이 분리된 후, 제1리니어(330)가 후진 동작한 후, 회전부(320)에 의해 혼합부(50)의 혼합용기(5)가 배치된 위치로 회전하며, 상기 항암제를 추출하는 동작과 같이 주사기(310) 바늘이 혼합용기(5)에 삽입되어 추출한 항암제를 혼합용기(5)에 주입하게 된다.Next, after the second linear 340 is moved backward to separate the needle of the syringe 310 from the anticancer agent vial 3, the first linear 330 is moved backward, and then the mixing unit ( The mixing container 5 of 50) rotates to a position where the anticancer agent is injected, and the needle 310 is inserted into the mixing container 5 to inject the extracted anticancer agent into the mixing container 5 as in the operation of extracting the anticancer agent. .
그 다음, 혼합용기(5)에 주입된 항암제 및 수액의 중량을 제1전자저울(520)를 통해 확인할 수 있게 된다.Then, the weight of the anticancer agent and the sap injected into the mixing container 5 can be confirmed through the first electronic balance 520.
한편, 상기 혼합용기(5)에 주입된 항암제와 혼합되기 위한 수액은 정량펌프(430)의 작동에 의해 수액백 설치부(410)에 설치된 수액백(2)으로부터 제1연결튜브(420)를 통해 정량펌프(430)를 거쳐 제2연결튜브(440)를 통해 혼합용기(5)로 주입되게 된다.On the other hand, the sap for mixing with the anticancer agent injected into the mixing vessel (5) is the first connecting tube 420 from the sap bag (2) installed in the sap bag installation unit 410 by the operation of the metering pump 430 Through the metering pump 430 through the second connecting tube 440 is to be injected into the mixing vessel (5).
한편, 대용량의 항암제가 사용될 경우에는, 수액백 설치부(410)에 항암제백(4)을 설치하고 제1연결튜브(420)를 항암제백(4)에 연결하여, 정량펌프(430)를 통해 혼합용기(5)로 주입할 수 있게 된다.On the other hand, when a large amount of anticancer agent is used, the anticancer agent bag 4 is installed in the sap bag installation unit 410 and the first connection tube 420 is connected to the anticancer agent bag 4 through a metering pump 430. It is possible to inject into the mixing vessel (5).
또한, 가루 형태의 항암제가 사용될 경우, 제2전자저울(610)에 항암제 바이알(3)을 배치한 후 수액을 주입하여 가루의 항암제와 수액의 혼합된 중량을 확인한 후 쉐이커(60)를 통해 수액에 가루 항암제가 용이하게 용해될 수 있도록 혼합시키고, 항암제와 수액의 혼합이 완료된 항암제 바이알(3)은 약품공급부(20)로 이송되어 사용된다.In addition, when the anticancer agent in powder form is used, the anticancer agent vial 3 is placed in the second electronic balance 610 and then injected with sap to check the mixed weight of the anticancer agent and sap of the powder, and then through the shaker 60. The powdered anticancer agent is mixed so that it can be easily dissolved, and the anticancer agent vial 3 in which the mixing of the anticancer agent and the sap is completed is transferred to the drug supply unit 20 and used.
이렇게, 수액과 항암제의 혼합이 완료되면 터치스크린(730)에 항암 주사제 조제 정보가 출력되고 약사는 이러한 정보를 확인한 후 조제 결과 정보가 기재된 바코드 라벨을 출력하여 혼합용기(5)에 부착하고 바코드를 바코드 리더기(720)로 읽어 데이터를 저장한다.When the mixing of the sap and the anticancer agent is completed, the anticancer injection preparation information is output on the touch screen 730, and the pharmacist checks this information, and then outputs a barcode label containing the preparation result information and attaches the mixed container 5 to the barcode. Read data to the barcode reader 720 to store the data.
그 다음, 조제가 완료된 항암 주사제는 외래 주사실로 전달되어 환자에게 주사하게 된다.The finished anticancer injection is then delivered to an outpatient injection room and injected into the patient.
상기 설명한 바와 같이, 주사장치(30)를 통해 약품공급부(20)에 설치된 항암제 바이알(3)로부터 정량의 항암제가 추출되어 혼합부(50)에 설치된 혼합용기(5)에 주입되고, 정량펌프(430)에 의해 수액공급부(40)에 설치된 수액백(2)으로부터 정량의 수액이 추출되어 혼합부(50)의 혼합용기(5)에 주입되어 정량의 항암제와 수액이 혼합된 항암제 주사제가 조제될 수 있게 된다.As described above, the anticancer agent of a certain amount is extracted from the anticancer agent vial 3 installed in the drug supply unit 20 through the injection device 30, and injected into the mixing container 5 installed in the mixing unit 50, and the metering pump ( 430 is extracted from the sap bag (2) installed in the sap supply unit 40 is injected into the mixing container (5) of the mixing section 50 to prepare an anticancer drug injection in which the quantitative anticancer agent and sap is mixed It becomes possible.
또한, 다량의 항암제가 사용될 경우 정량펌프(430)를 이용하여 항암제를 혼합부(50)의 혼합용기(5)에 주입하고, 가루 형태의 항암제가 사용될 경우 수액을 주입하고 쉐이커(60)를 통해 항암제가 수액에 용해되어 혼합될 수 있게 된다.In addition, when a large amount of anticancer agent is used, the anticancer agent is injected into the mixing container 5 of the mixing unit 50 by using the metering pump 430, and when a powdered anticancer agent is used, infusion of sap is made through the shaker 60. The anticancer agent can be dissolved in the sap and mixed.
이에 따라, 자동화설비를 통해 약사의 개입을 최소화하여 인력을 감소시키고, 항암제와 직접적인 접촉을 줄여 안전성을 확보할 수 있으며, 정량의 항암제와 수액을 혼합함으로써 항암제 주사제 조제의 정확성을 향상시킬 수 있는 특징이 있는 것이다.Accordingly, the automated facility minimizes the intervention of the pharmacist to reduce manpower, secures safety by reducing direct contact with the anticancer agent, and improves the accuracy of the anticancer injection preparation by mixing the quantitative anticancer agent and the sap. Is there.
이하에서는, 본 발명의 또 다른 실시예에 따른 항암 주사제 조제장치를 첨부한 도 5 내지 도 7을 참조하여 상세히 설명한다.Hereinafter, with reference to Figures 5 to 7 attached to the anticancer injection preparation device according to another embodiment of the present invention will be described in detail.
도 5는 본 발명의 또 다른 실시예에 따른 항암 주사제 조제장치의 요부 구성을 나타낸 도면, 도 6 및 도 7은 본 발명의 또 다른 실시예에 따른 항암 주사제 조제장치의 개략적인 작동을 나타낸 작동상태도이다.5 is a view showing the main configuration of the anticancer injection preparation device according to another embodiment of the present invention, Figure 6 and Figure 7 is an operating state showing the schematic operation of the anticancer injection preparation device according to another embodiment of the present invention to be.
도 5 내지 도 7을 참조하여 설명하면, 본 발명의 또 다른 실시예에 따른 항암 주사제 조제장치(1)는 승강부(80) 및 지지부(90)를 더 포함한다.5 to 7, the anticancer injection preparation device 1 according to another embodiment of the present invention further includes a lift unit 80 and a support unit 90.
상기 승강부(80)에는 상기 약품공급부(20) 및 상기 주사장치(30)가 결합될 수 있다. 상기 승강부(80)는 상기 약품공급부(20) 및 상기 주사장치(30)를 승강시킬 수 있다. 상기 승강부(80)는 일측에 상기 제1고정부재(210)가 결합될 수 있다. 상기 제1고정부재(210)에는 약품공급부(20)가 결합될 수 있다. 상기 약품공급부(20)는 상기 제1고정부재(210)에 결합된 상태에서 상기 회전축(211)을 중심으로 회전할 수 있다. 상기 승강부(80)는 타측이 상기 지지부(90)에 결합될 수 있다. 상기 승강부(80)는 상기 지지부(90)에 삽입 가능하도록 상기 지지부(90)에 결합될 수 있다. 상기 약품공급부(20) 및 상기 주사장치(30)는 상기 승강부(80)의 일측과 타측 사이에 위치되도록 상기 승강부(80)에 결합될 수 있다. 상기 승강부(80)는 상기 약품공급부(20) 및 상기 주사장치(30)를 상측방향 또는 하측방향으로 이동시킬 수 있다. 상기 승강부(80)는 상기 지지부(90)의 내부에 일부 또는 전부가 삽입됨으로써, 상기 약품공급부(20) 및 상기 주사장치(30)를 하측방향으로 이동시킬 수 있다. 상기 승강부(80)는 상기 지지부(90)에 삽입되는 방향과 반대되는 방향으로 상기 지지부(90)로부터 돌출됨으로써, 상기 약품공급부(20) 및 상기 주사장치(30)를 상측방향으로 이동시킬 수 있다. 상기 승강부(80)는 상기 무균조제대(10)에서 항암 주사제가 조제된 경우에 상기 약품공급부(20) 및 상기 주사장치(30)를 하측방향으로 이동시킬 수 있다. 상기 승강부(90)가 하측방향으로 이동되면, 약사나 항암 주사제 조제자는 상기 무균조제대(10)의 개방된 입구를 통해 상기 약품공급부(20)를 상기 승강부(80)에 장착하거나 상기 승강부(80)로부터 상기 약품공급부(20)를 떼어내어 제거할 수 있다. 이 경우, 상기 약품공급부(20)에 수용되어 있던 항암제는 상기 주사장치(30)에 의해 상기 혼합용기(5)로 주입되었므로, 상기 약품공급부(20)의 항암제 바이알(3)들은 비어있는 상태일 수 있다. 따라서, 상기 혼합용기(5)에는 항암 주사제가 수용될 수 있다. 상기 승강부(80)는 상기 주사기(310)가 상기 회전부(320)에 의해 회전된 후에 하측방향으로 이동될 수 있다. 예컨대, 상기 주사기(310)는 상기 회전부(320)에 의해 상기 승강부(80)의 상하 이동방향과 수직한 수직방향으로 회전될 수 있다. 이는 상기 승강부(80)의 일측에 결합된 상기 약품공급부(20)를 상기 무균조제대(10)의 개방된 입구까지 위치되도록 하측방향으로 이동시키기 위함이다. 상기 승강부(80)가 하측방향으로 이동된 상태에서 상기 승강부(80)의 일측에 새로운 약품공급부(20)가 설치되면, 상기 승강부(80)는 상기 지지부(90)로부터 돌출됨으로써 상기 약품공급부(20) 및 상기 주사장치(30)를 상측방향으로 이동시킬 수 있다. 이 경우, 상기 새로운 약품공급부(20)의 항암제 바이알(3)들은 항암제가 채워진 새로운 항암제 바이알(3)들이 약사나 조제자에 의해 상기 제1고정부재(210)에 설치된 것일 수 있다. 상기 승강부(80)는 새로운 약품공급부(20)로부터 항암 주사제를 조제하기 위해 새로운 약품공급부(20) 및 주사장치(30)를 상측방향으로 이동시킬 수 있다. 이 때, 항암 주사제가 주입된 혼합용기(5)도 내부가 비어있는 새로운 혼합용기(5)로 약사나 조제자에 의해 교체될 수 있다. 상기 승강부(80)가 상기 약품공급부(20) 및 상기 주사장치(30)를 상측방향으로 이동시킨 후에 상기 수직방향으로 회전된 주사기(310)는 다시 항암제 바이알(310)로부터 항암제를 추출하기 위한 방향으로 회전될 수 있다. 상기 승강부(80)는 전체적인 형태가 원기둥으로 형성될 수 있으나, 이에 한정되지 않으며 상기 약품공급부(20) 및 상기 주사장치(30)를 승강시킬 수 있으면 직방체 등 다른 형태로 형성될 수도 있다. 상기 승강부(80)는 유압실린더 또는 공압실린더를 이용한 실린더방식, 모터와 랙기어(Rack Gear)와 피니언기어(Pinion Gear) 등을 이용한 기어방식, 모터와 볼스크류(Ball Screw) 등을 이용한 볼스크류방식, 모터와 풀리와 벨트 등을 이용한 벨트방식, 코일과 영구자석을 이용한 리니어모터(Linear Motor) 방식 등을 이용하여 상기 약품공급부(20) 및 상기 주사장치(30)를 상하방향으로 이동시킬 수 있다. 상기 승강부(80)는 상기 지지부(90)에 설치되는 엘엠가이드레일(Lm Guide Rail)을 따라 이동하는 엘엠블록(Lm Block)을 포함할 수도 있다.The medicine supply unit 20 and the injection device 30 may be coupled to the lifting unit 80. The lifting unit 80 may raise and lower the medicine supply unit 20 and the injection device 30. The lifting unit 80 may be coupled to the first fixing member 210 on one side. The drug supply unit 20 may be coupled to the first fixing member 210. The drug supply unit 20 may rotate about the rotation shaft 211 in a state coupled to the first fixing member 210. The lifting portion 80 may be coupled to the support portion 90 on the other side. The lifting unit 80 may be coupled to the support unit 90 to be inserted into the support unit 90. The drug supply unit 20 and the injection device 30 may be coupled to the lifting unit 80 to be located between one side and the other side of the lifting unit 80. The lifting unit 80 may move the drug supply unit 20 and the injection device 30 in an upward direction or a downward direction. The elevating part 80 may be partially or entirely inserted into the support part 90 to move the medicine supply part 20 and the injection device 30 downward. The elevating unit 80 protrudes from the support unit 90 in a direction opposite to the direction of insertion into the support unit 90, thereby moving the drug supply unit 20 and the injection device 30 upward. have. The lifting unit 80 may move the drug supply unit 20 and the injection device 30 downward when the anticancer injection agent is prepared in the sterile preparation table 10. When the lifting unit 90 is moved downward, the pharmacist or anticancer injection agent is mounted on the lifting unit 80 or the lifting unit 80 through the open inlet of the aseptic preparation 10 The drug supply unit 20 can be removed from the unit 80 and removed. In this case, since the anticancer agent contained in the drug supply unit 20 was injected into the mixing container 5 by the injection device 30, the anticancer agent vials 3 of the drug supply unit 20 are empty. Can be. Therefore, the anticancer injection may be accommodated in the mixing container 5. The lifting unit 80 may be moved downward after the syringe 310 is rotated by the rotating unit 320. For example, the syringe 310 may be rotated by the rotating part 320 in a vertical direction perpendicular to the vertical movement direction of the lifting part 80. This is to move the drug supply unit 20 coupled to one side of the lifting unit 80 in the downward direction to be located to the open inlet of the aseptic preparation 10. When the new medicine supply unit 20 is installed on one side of the elevating unit 80 in the state in which the elevating unit 80 is moved downward, the elevating unit 80 protrudes from the support unit 90 such that the chemicals The supply unit 20 and the injection device 30 may be moved upward. In this case, the anticancer agent vials 3 of the new drug supply unit 20 may be the new anticancer agent vials 3 filled with the anticancer agent installed on the first fixing member 210 by a pharmacist or a pharmacist. The lifting unit 80 may move the new drug supply unit 20 and the injection device 30 upward to prepare an anticancer injection from the new drug supply unit 20. At this time, the mixing container 5 into which the anticancer injection is injected may also be replaced by a pharmacist or a formulator with a new mixing container 5 having an empty inside. After the elevating unit 80 moves the drug supply unit 20 and the injection device 30 upward, the syringe 310 rotated in the vertical direction again extracts an anticancer agent from the anticancer agent vial 310. Direction can be rotated. The lifting unit 80 may be formed in a cylindrical shape, but is not limited thereto, and may be formed in another shape such as a rectangular parallelepiped if the medicine supply unit 20 and the injection device 30 can be elevated. The lifting unit 80 is a cylinder method using a hydraulic cylinder or a pneumatic cylinder, a gear method using a motor and a rack gear and a pinion gear, a ball using a motor and a ball screw, etc. The chemical supply unit 20 and the injection device 30 may be moved upward and downward by using a screw method, a belt method using a motor, a pulley and a belt, or a linear motor method using a coil and a permanent magnet. Can be. The lifting unit 80 may include an Lm block moving along an Lm guide rail installed in the support unit 90.
상기 지지부(90)는 상기 무균조제대(10)에 설치된다. 예컨대, 상기 지지부(90)는 상기 정량펌프(430)와 상기 제2전자저울(610) 사이에 위치되도록 상기 무균조제대(10)에 설치될 수 있다. 상기 지지부(90)에는 상기 승강부(80)가 삽입 가능하게 결합될 수 있다. 상기 지지부(90)는 상기 무균조제대(10)에 지지되어 상기 승강부(80)를 지지할 수 있다. 상기 지지부(90)는 전체적인 형태가 내부가 비어있는 직방체로 형성될 수 있으나, 이에 한정되지 않으며 상기 승강부(80)를 지지할 수 있고, 상기 승강부(80)의 일부 또는 전부가 내부로 삽입될 수 있으면 내부가 비어있는 사다리꼴 형태 등 다른 형태로 형성될 수도 있다.The support 90 is installed on the aseptic preparation table 10. For example, the support 90 may be installed on the aseptic preparation 10 so as to be located between the metering pump 430 and the second electronic balance 610. The lifting unit 80 may be coupled to the support unit 90 to be insertable. The support 90 may be supported by the aseptic preparation table 10 to support the lifting unit 80. The support portion 90 may be formed as a rectangular parallelepiped in an overall shape, but is not limited thereto. The support portion 90 may support the lifting portion 80, and part or all of the lifting portion 80 may be inserted into the support body 90. If possible, it may be formed in other shapes such as trapezoidal shape with an empty interior.
이에 따라, 본 발명의 또 다른 실시예에 따른 항암 주사제 조제장치(1)는 항암 주사제의 조제가 완료된 후에 상기 약품공급부(20)를 상기 무균조제대(2)의 개방된 입구까지 위치시킬 수 있으므로, 약사나 조제자가 상기 개방된 입구를 통해 약품공급부(20)를 상기 승강부(80)로부터 용이하게 제거하거나 상기 승강부(80)에 용이하게 설치할 수 있다. 따라서, 본 발명의 또 다른 실시예에 따른 항암 주사제 조제장치(1)는 약사나 조제자에게 근골격계 질환과 같은 산업재해가 발생하는 것을 방지할 수 있다.Accordingly, since the anticancer injection preparation device 1 according to another embodiment of the present invention can place the drug supply unit 20 to the open inlet of the sterile preparation 2 after the preparation of the anticancer injection is completed. The pharmacist or the pharmacist can easily remove the medicine supply unit 20 from the lifting unit 80 through the open inlet or easily install the lifting unit 80. Therefore, the anticancer injection preparation device 1 according to another embodiment of the present invention can prevent an industrial accident such as a musculoskeletal disorder from occurring in a pharmacist or a preparation person.
이하에서는, 본 발명에 따른 항암 주사제 조제시스템(1000)의 실시예를 첨부된 도면을 참조하여 구체적으로 설명한다.Hereinafter, with reference to the accompanying drawings an embodiment of the anticancer injection preparation system 1000 according to the present invention will be described in detail.
도 8은 본 발명에 따른 항암 주사제 조제시스템을 나타낸 개략적인 작동상태도이다.8 is a schematic operation state diagram showing an anticancer injection preparation system according to the present invention.
도 8을 참조하여 설명하면, 본 발명에 따른 항암 주사제 조제시스템(1000)은 공급부(1100), 항암 주사제 조제장치, 이송로봇(1200) 및 반출부(1300)를 포함할 수 있다. 상기 항암 주사제 조제장치는 상술한 본 발명에 따른 항암 주사제 조제장치(1)와 대략 일치하므로, 이에 대한 구체적인 설명은 생략한다.Referring to FIG. 8, the anticancer injection preparation system 1000 according to the present invention may include a supply unit 1100, an anticancer injection preparation device, a transfer robot 1200, and an export unit 1300. Since the anticancer injection preparation device is substantially the same as the anticancer injection preparation device 1 according to the present invention described above, a detailed description thereof will be omitted.
상기 공급부(1100)는 항암제가 수용된 복수개의 항암제 바이알이 고정되어 복수개의 항암제 바이알 중 어느 하나가 선택되어 항암제를 공급하는 약품공급부(20), 및 항암제와 수액을 혼합하기 위한 혼합용기(5)를 공급하기 위한 것이다. 상기 공급부(1100)는 상기 무균조제대(2)의 외부에서 상기 이송로봇(1200)이 상기 항암 주사제 조제장치(1)로 이송 가능한 공급이송영역(SA, 도 8에 도시됨)까지 상기 약품공급부(20)와 상기 혼합용기(5)를 공급하기 위한 것이다. 즉, 상기 공급부(1100)는 상기 무균조제대(2)의 외부와 상기 이송로봇(1200)의 공급이송영역(SA)을 연결하도록 설치된다. 상기 이송로봇(1200)의 공급이송영역(SA)은 다관절로 이루어진 이송로봇(1200)이 상기 공급부(1100)에서 공급되는 상기 약품공급부(20)와 상기 혼합용기(5)를 파지하여 이동시킬 수 있는 영역을 의미한다. 상기 공급부(1100)는 상기 무균조제대(2)의 외부에서 약사나 조제자가 공급하는 상기 약품공급부(20) 및 상기 혼합용기(5)를 상기 이송로봇(1200)의 공급이송영역(SA)까지 공급할 수 있다. 상기 공급부(1100)는 상기 약품공급부(20)와 상기 혼합용기(5)를 지지하여 이동시킬 수 있는 컨베이어(Conveyor)일 수 있다. 상기 무균조제대(2)의 외부에 위치하는 약사나 조제자는 환자의 처방전에 따라 다른 종류의 항암제가 수용된 약품공급부(20)를 상기 공급부(1100)에 공급할 수 있다. 상기 공급부(1100)는 한쌍으로 이루어진 약품공급부(20) 및 혼합용기(5)를 복수개 이동시킬 수 있다. 상기 공급부(1100)는 상기 무균조제대(2)의 외부에서 약사나 조제자가 환자들에 따라 각각 다르게 세팅한 복수개의 약품공급부(20) 및 혼합용기(5)를 순차적으로 올려놓음으로써, 복수개의 약품공급부(20) 및 혼합용기(5)를 순차적으로 상기 공급이송영역(SA)으로 이동시킬 수 있다. 상기 공급부(3)는 한쌍으로 이루어진 약품공급부(20) 및 혼합용기(5)를 상기 공급이송영역(SA)에 공급하면 상기 이송로봇(1200)이 상기 한쌍의 약품공급부(20) 및 혼합용기(5)를 상기 항암 주사제 조제장치(1)에 이송할 때까지 회전이 정지될 수 있다. 상기 공급부(3)는 상기 이송로봇(1200)이 상기 한쌍의 약품공급부(20) 및 혼합용기(5)를 상기 항암 주사제 조제장치(1)에 이송한 후 다시 공급이송영역(SA)에 위치되면, 회전할 수 있다.The supply unit 1100 has a plurality of anticancer vials containing an anticancer agent is fixed to any one of the plurality of anticancer vials to supply the drug supply unit 20 for supplying the anticancer agent, and the mixing vessel 5 for mixing the anticancer agent and the sap It is to supply. The supply unit 1100 is the drug supply unit from the outside of the sterile preparation table 2 to the supply transfer area (SA, shown in Figure 8) that the transfer robot 1200 can be transferred to the anticancer injection preparation device (1) (20) and the mixing vessel (5) for supplying. That is, the supply unit 1100 is installed to connect the outside of the sterile preparation table 2 with the supply transfer area SA of the transfer robot 1200. The feed transfer area SA of the transfer robot 1200 may be moved by holding the chemical supply unit 20 and the mixing vessel 5 supplied from the supply unit 1100 by the transfer robot 1200 formed of multiple joints. It means the area that can be. The supply unit 1100 is the drug supply unit 20 and the mixing vessel (5) supplied by the pharmacist or formulator from the outside of the sterile preparation table (2) to the supply transfer area (SA) of the transfer robot 1200 Can supply The supply unit 1100 may be a conveyor capable of supporting and moving the chemical supply unit 20 and the mixing container 5. A pharmacist or pharmacist located outside of the sterile dispensing table 2 may supply the supply unit 1100 with a medicine supply unit 20 containing other types of anticancer agents according to a patient's prescription. The supply unit 1100 may move a plurality of pairs of the chemical supply unit 20 and the mixing vessel (5). The supply unit 1100 by sequentially placing a plurality of drug supply unit 20 and the mixing vessel (5) set by the pharmacist or formulator differently from the outside of the sterile preparation table 2, a plurality of The chemical supply unit 20 and the mixing container 5 may be sequentially moved to the supply transfer area SA. The supply unit 3 supplies a pair of chemical supply unit 20 and the mixing vessel 5 to the supply transfer area SA, the transfer robot 1200 is the pair of chemical supply unit 20 and the mixing vessel ( Rotation may be stopped until 5) is transferred to the anticancer injection preparation device 1. The supply unit 3 is located in the supply transfer area SA after the transfer robot 1200 transfers the pair of drug supply units 20 and the mixing container 5 to the anticancer injection preparation device 1 again. Can rotate.
상기 이송로봇(1200)은 상기 공급부(1100)로부터 공급되는 약품공급부(20)와 혼합용기(5)를 상기 항암 주사제 조제장치(1)로 이송하거나 상기 항암 주사제 조제장치(1)로부터 약품공급부와 혼합용기를 이송하기 위한 것이다. 상기 이송로봇(1200)은 다관절로 이루어진 로봇으로써, 다관절의 움직임을 통해 길이가 신장되거나 축소되어 약품공급부와 혼합용기와 같은 물품들을 파지하거나 파지한 물품들을 놓을 수 있다. 상기 이송로봇(1200)은 바닥에 고정되게 설치되어 회전됨으로써, 서로 다른 방향에 위치한 물품들을 서로 다른 위치로 신속하게 이동시킬 수 있다. 상기 이송로봇(1200)은 항암 주사제를 조제할 경우, 상기 공급부(1100)로부터 공급되는 항암제가 수용된 약품공급부(20)와 비어있는 혼합용기(5)를 상기 공급이송영역(SA)에서 파지하여 상기 항암 주사제 조제장치(1)로 이송할 수 있다. 상기 이송로봇(1200)은 상기 항암 주사제 조제장치(1)에서 항암 주사제가 조제되어 수용된 혼합용기(5) 및 비어있는 항암제 바이알들을 포함하는 약품공급부(20)를 파지하여 상기 항암 주사제 조제장치(1)로부터 반출부(1300)로 이송할 수 있다. 이 경우, 상기 이송로봇(1200)은 반출이송영역(CA, 도 8에 도시됨)으로 상기 약품공급부(20) 및 상기 혼합용기(5)를 이송할 수 있다. 상기 반출이송영역(CA)은 상기 반출부(1300)가 설치되는 영역으로, 상기 이송로봇(1200)에 의해 상기 항암 주사제 조제장치(1)로부터 이송되는 약품공급부(20) 및 혼합용기(5)가 상기 반출부(1300)에 올려지게 되는 영역이다. 상기 이송로봇(1200)은 상기 공급부(1100)와 상기 항암 주사제 조제장치(1), 및 상기 항암 주사제 조제장치(1)와 상기 반출부(1300) 사이를 회전하여 약품공급부(20) 및 혼합용기(5)를 이송할 수 있다. 도시되지 않았지만, 상기 이송로봇(1200)은 약사나 조제자에 의해 잘못 처방된 약품공급부(20)가 공급부(1100)를 통해 이송될 경우, 상기 공급부(1100)에서 잘못 처방된 약품공급부(20)를 파지하여 바로 반출부(1300)로 이송시킬 수도 있다.The transport robot 1200 transfers the drug supply unit 20 and the mixing container 5 supplied from the supply unit 1100 to the anticancer injection preparation device 1 or the drug supply unit from the anticancer injection preparation device 1. To convey the mixed container. The transfer robot 1200 is a multi-joint robot, the length of which is extended or shortened through the movement of the articulated joints to hold or grasp items such as chemical supply unit and the mixing vessel. The transport robot 1200 is fixedly installed on the floor and rotated, thereby quickly moving items located in different directions to different locations. When the anti-cancer injection agent is prepared, the transfer robot 1200 grips the drug supply unit 20 and the empty mixing container 5 containing the anticancer agent supplied from the supply unit 1100 in the supply transfer area SA. It can be transferred to the anticancer injection preparation device 1. The transport robot 1200, the anticancer injection preparation device (1) by holding the drug supply unit 20 containing a mixed container (5) and empty anticancer drug vials prepared by receiving an anticancer injection drug (1) ) May be transferred to the carry-out unit 1300. In this case, the transfer robot 1200 may transfer the drug supply unit 20 and the mixing container 5 to the export transfer area (CA, shown in Figure 8). The carry-out transport area CA is an area in which the carry-out part 1300 is installed, and the medicine supply part 20 and the mixing container 5 transferred from the anticancer injection preparation device 1 by the transport robot 1200. Is an area to be placed on the carry-out unit 1300. The transport robot 1200 rotates between the supply unit 1100 and the anticancer injection preparation device 1, and the anticancer injection preparation device 1 and the discharge unit 1300 to supply a medicine supply unit 20 and a mixing container. (5) can be transported. Although not shown, the transfer robot 1200 is incorrectly prescribed by the pharmacist or pharmacist, if the drug supply unit 20 is transferred through the supply unit 1100, incorrectly prescribed drug supply unit 20 in the supply unit 1100 It may be transferred to the carrying out portion 1300 immediately by holding.
상기 이송로봇(1200)은 복수개의 항암 주사제 조제장치(1)가 설치될 경우, 상기 항암 주사제 조제장치(1)들의 가운데에 위치되도록 설치될 수 있다. 즉, 상기 항암 주사제 조제장치(1)들은 각각 상기 이송로봇(1200)으로부터 이격된 이격거리(DL, 도 8에 도시됨)가 동일하도록 설치될 수 있다. 이에 따라, 본 발명에 따른 항암 주사제 조제시스템(1000)은 상기 이송로봇(1200)이 각각의 항암 주사제 조제장치(1)로 이동하지 않아도 바닥에 고정된 상태에서 회전함으로써, 상기 공급부(1100)에서 각각의 항암 주사제 조제장치(1)들로 약품공급부(20) 및 혼합용기(5)를 신속하게 이송하거나 상기 항암 주사제 조제장치(1)들로부터 상기 반출부(1300)로 약품공급부(20) 및 혼합용기(5)를 신속하게 이송할 수 있다.The transport robot 1200 may be installed to be positioned in the middle of the anticancer injection preparations 1 when a plurality of anticancer injection preparations 1 are installed. That is, the anticancer injection preparation devices 1 may be installed such that the separation distance DL (shown in FIG. 8) spaced apart from the transport robot 1200 is the same. Accordingly, the anticancer injection preparation system 1000 according to the present invention is rotated in a fixed state on the floor even if the transfer robot 1200 does not move to each anticancer injection preparation device 1, thereby providing a Rapidly transfer the drug supply unit 20 and the mixing vessel 5 to the respective anticancer injection preparations 1 or the drug supply unit 20 and from the anticancer injection preparations 1 to the discharge unit 1300. The mixing container 5 can be conveyed quickly.
상기 이송로봇(1200)은 상기 공급부(1100)에서 공급되는 약품공급부(20) 및 혼합용기(5)를 상기 공급이송영역(SA)에서 파지하여, 상기 항암 주사제 조제장치(1)의 승강부(80) 및 용기고정부(510)에 각각 상기 약품공급부(20) 및 상기 혼합용기(5)를 설치할 수 있다. 이 경우, 상기 승강부(80)는 상기 무균조제대(10)의 개방된 입구까지 하측방향으로 이동된 상태일 수 있다. 상기 승강부(80)는 상기 이송로봇(1200)에 의해 약품공급부(20)가 설치되면 상측방향으로 상기 약품공급부(20)를 이동시킬 수 있다. 그리고, 상기 이송로봇(1200)에 의해 상기 용기고정부(510)에 혼합용기(5)가 설치되면, 비로소 상기 항암 주사제 조제장치(1)는 항암 주사제를 조제할 수 있다. 상기 이송로봇(1200)은 상기 항암 주사제 조제장치(1)에서 항암 주사제가 조제되어 상기 승강부(80)가 비어있는 항암제 바이알(3)들을 포함하는 약품공급부(20)를 하측방향으로 이동시키면, 상기 무균조제대(10)의 개방된 입구를 통해 상기 승강부(80)로부터 상기 약품공급부(20)를 파지하여 상기 반출부(1300)로 이송시킬 수 있다. 상기 이송로봇(1200)은 상기 용기고정부(510)로부터 항암 주사제가 수용된 혼합용기(5)를 파지하여 상기 반출부(1300)로 이송시킬 수도 있다. The transfer robot 1200 grips the drug supply unit 20 and the mixing vessel 5 supplied from the supply unit 1100 in the supply transfer area SA, thereby raising and lowering the anticancer injection preparation device 1 ( 80) and the container fixing portion 510 may be provided with the chemical supply unit 20 and the mixing container (5), respectively. In this case, the lifting unit 80 may be in a state moved downward to the open inlet of the aseptic preparation 10. The elevating unit 80 may move the chemical supply unit 20 in an upward direction when the chemical supply unit 20 is installed by the transfer robot 1200. When the mixing container 5 is installed in the container fixing part 510 by the transfer robot 1200, the anticancer injection preparation device 1 may prepare an anticancer injection. When the transport robot 1200 moves the drug supply unit 20 including the anticancer agent vials 3, wherein the anticancer injection agent is prepared in the anticancer injection preparation device 1 and the lift unit 80 is empty, The drug supply unit 20 may be gripped from the lift unit 80 through the open inlet of the sterile preparation table 10 and then transferred to the discharge unit 1300. The transfer robot 1200 may grip the mixed container 5 containing the anticancer injection agent from the container fixing part 510 and transfer the same to the discharge unit 1300.
상기 반출부(1300)는 상기 이송로봇(1200)에 의해 상기 항암 주사제 조제장치(1)로부터 이송되는 약품공급부(20)와 항암 주사제가 수용된 혼합용기(5)를 반출하기 위한 것이다. 상기 반출부(1300)는 상기 반출이송영역(CA)과 외부를 연결하도록 설치된다. 상기 반출부(1300)는 상기 이송로봇(1200)에 의해 이송되는 약품공급부(20)와 혼합용기(5)를 지지하여 외부로 반출시킬 수 있다. 상기 반출부(1300)는 상기 반출이송영역(CA)과 외부 사이에서 회전하는 컨베이어(Conveyor)일 수 있다. 상기 반출부(1300)는 상기 이송로봇(1200)에서 순차적으로 이송되는 한쌍으로 이루어진 약품공급부(20) 및 혼합용기(5)를 외부로 반출할 수 있다. 상기 반출부(1300)에서 반출되는 항암 주사제가 수용된 혼합용기(5)는 약사나 조제자에 의해 주사실, 약국 등 다른 장소로 이동될 수 있다. 상기 반출부(1300)에서 반출되는 비어있는 항암제 바이알들을 포함하는 약품공급부(20)는 항암제 바이알을 재사용하기 위한 세척부나 재활용부로 이동될 수 있다.The carrying out unit 1300 is for carrying out the medicine supply unit 20 and the mixing container 5 in which the anticancer injection agent is transferred from the anticancer injection preparation device 1 by the transfer robot 1200. The carrying out unit 1300 is installed to connect the carrying out area CA and the outside. The carrying out unit 1300 may carry the chemical supply unit 20 and the mixing container 5 transported by the transfer robot 1200 to be carried out to the outside. The carrying out unit 1300 may be a conveyor that rotates between the carrying out area CA and the outside. The carrying out unit 1300 may carry out a pair of chemical supply unit 20 and the mixing vessel (5) made to be sequentially transferred from the transfer robot 1200 to the outside. The mixed container 5 containing the anticancer injection taken out from the carrying out unit 1300 may be moved to another place such as an injection room or a pharmacy by a pharmacist or a pharmacist. The drug supply unit 20 including empty anticancer vials to be taken out from the carrying out unit 1300 may be moved to a washing unit or a recycling unit for reusing the anticancer agent vials.
이에 따라, 본 발명에 따른 항암 주사제 조제시스템(1000)은 다음과 같은 작용 효과를 도모할 수 있다.Accordingly, the anticancer injection preparation system 1000 according to the present invention can achieve the following effects.
첫째, 본 발명에 따른 항암 주사제 조제시스템(1000)은 상기 공급부(1100)와 상기 반출부(1300)를 각각 상기 공급이송영역(SA)과 상기 반출이송영역(CA)에 연결되도록 설치함으로써, 외부에서 상기 항암 주사제 조제장치(1)에 약품공급부(20) 및 혼합용기(5)를 용이하게 공급하고 배출시킬 수 있다. 이에 따라, 본 발명에 따른 항암 주사제 조제시스템(1000)은 약사나 조제자에게 근골격계 질환과 같은 산업재해가 발생하는 것을 방지할 수 있을 뿐만 아니라 항암 주사제를 조제하는 항암 주사제 조제장치(1)에 오염물질이 침투하는 것을 방지할 수 있다.First, the anticancer injection preparation system 1000 according to the present invention is provided by connecting the supply unit 1100 and the export unit 1300 to the supply transfer area SA and the export transfer area CA, respectively. In the anticancer injection preparation device 1 can easily supply and discharge the drug supply unit 20 and the mixing container (5). Accordingly, the anticancer injection preparation system 1000 according to the present invention not only prevents industrial accidents such as musculoskeletal disorders from occurring in the pharmacist or pharmacist, but also contaminates the anticancer injection preparation device 1 for preparing the anticancer injection. It is possible to prevent the substance from penetrating.
둘째, 본 발명에 따른 항암 주사제 조제시스템(1000)은 상기 이송로봇(1200)을 이용하여 복수개의 항암 주사제 조제장치(1) 각각에 신속하게 약품공급부(20) 및 혼합용기(5)를 공급 및 배출시킬 수 있으므로, 대량의 항암 주사제를 신속하게 조제할 수 있다.Second, the anticancer injection preparation system 1000 according to the present invention quickly supplies the medicine supply unit 20 and the mixing container 5 to each of the plurality of anticancer injection preparations 1 by using the transfer robot 1200. Since it can discharge, a large amount of anticancer injections can be prepared quickly.
도시되지 않았지만, 본 발명에 따른 항암 주사제 조제시스템(1000)은 상기 공급부(1100)와 상기 반출부(1300)에 각각 이송로봇을 설치함으로써, 항암 주사제에 대한 조제작업을 전자동화시킬 수도 있다. 또한, 본 발명에 따른 항암 주사제 조제시스템(1000)은 약품공급부(20)에 복수개의 항암제 바이알(3) 뿐만 아니라 혼합용기(5)를 포함시킴으로써, 상기 이송로봇(1200)이 한번의 이송으로 약품공급부(20) 및 혼합용기(5)를 상기 항암 주사제 조제장치(1)에 공급하거나 배출시킬 수 있다. 이에 따라, 본 발명에 따른 항암 주사제 조제시스템(1000)은 상기 항암 주사제 조제장치(1)에 약품공급부(20) 및 혼합용기(5)를 공급 및 배출시키는 시간을 단축시킴으로써, 항암 주사제를 조제하는데 걸리는 시간을 더 단축시킬 수 있다.Although not shown, the anticancer injection preparation system 1000 according to the present invention may install a transfer robot in the supply unit 1100 and the export unit 1300, respectively, to fully automate the preparation of the anticancer injection. In addition, the anticancer injection preparation system 1000 according to the present invention includes a mixing container 5 as well as a plurality of anticancer drug vials 3 in the drug supply unit 20, so that the transport robot 1200 is a single drug transporting. The supply unit 20 and the mixing container 5 may be supplied to or discharged from the anticancer injection preparation device 1. Accordingly, the anticancer injection preparation system 1000 according to the present invention shortens the time for supplying and discharging the drug supply unit 20 and the mixing container 5 to the anticancer injection preparation device 1, thereby preparing an anticancer injection. The time taken can be further shortened.
한편, 본 발명은 앞서 설명한 실시예로 한정되는 것이 아니라 본 발명의 요지를 벗어나지 않는 범위 내에서 수정 및 변형하여 실시할 수 있고, 그러한 수정 및 변형이 가해진 것도 본 발명의 기술적 사상에 속하는 것으로 보아야 한다.Meanwhile, the present invention is not limited to the above-described embodiments, but may be modified and modified without departing from the scope of the present invention, and such modifications and variations should be regarded as belonging to the technical spirit of the present invention. .

Claims (12)

  1. 무균실 내에 설치되어 항암제 주사제를 조제하는 조제실이 구비된 무균조제대;A sterile preparation stage provided in a sterile chamber and having a preparation room for preparing an anticancer drug injection;
    상기 무균조제대에 설치되고, 항암제가 수용된 복수개의 항암제 바이알이 고정되어, 복수개의 항암제 바이알 중 어느 하나가 선택되어 항암제를 공급하는 약품공급부;A drug supply unit installed in the sterile preparation station and fixed with a plurality of anticancer agent vials containing an anticancer agent, and selecting any one of a plurality of anticancer agent vials to supply an anticancer agent;
    상기 약품공급부에 설치된 항암제 바이알 위치와 정렬될 수 있도록 작동되고, 약품공급부에 설치된 항암제 바이알로부터 항암제를 추출하여 수액이 수용된 곳으로 추출한 항암제를 주입하기 위한 주사장치;An injection device operable to be aligned with a location of an anticancer agent vial installed in the drug supply unit, and extracting an anticancer agent from the anticancer agent vial installed in the drug supply unit and injecting the anticancer agent extracted into the place where the sap is accommodated;
    상기 무균조제대에 설치되고, 항암제와 혼합되는 수액을 공급하기 위한 수액공급부; 및Sap supply unit is installed in the aseptic preparation, for supplying the sap mixed with the anticancer agent; And
    상기 주사장치로부터 공급받은 항암제와 수액공급부로부터 공급받은 수액을 혼합하기 위해 혼합용기가 구비된 혼합부;를 포함하는 것을 특징으로 하는 항암 주사제 조제장치.And a mixing unit provided with a mixing container for mixing the anticancer agent supplied from the injection device with the sap supplied from the infusion supplying unit.
  2. 제 1항에 있어서,The method of claim 1,
    상기 약품공급부 및 상기 주사장치가 결합되고, 상기 약품공급부 및 상기 주사장치를 승강시키기 위한 승강부; 및An elevation unit coupled to the drug supply unit and the injection device and configured to elevate the drug supply unit and the injection device; And
    상기 무균조제대에 설치되고, 상기 승강부를 지지하기 위한 지지부를 포함하고,It is installed on the aseptic tank, and includes a support for supporting the lifting unit,
    상기 승강부는 상기 지지부에 삽입 가능하도록 상기 지지부에 결합되는 것을 특징으로 하는 항암 주사제 조제장치.The elevating unit is anticancer injection preparation device characterized in that coupled to the support to be inserted into the support.
  3. 제 1항에 있어서,The method of claim 1,
    상기 약품공급부는,The drug supply unit,
    상기 무균조제대에 설치되고, 수직상의 어느 한 축을 중심으로 회전하면서 항암제 바이알이 주사장치와 정렬되어 배치될 수 있도록 설치되는 제1고정부재; 및A first fixing member installed on the sterile preparation table and installed to align the anticancer drug vial with the injection device while rotating about one vertical axis; And
    상기 무균조제대에 설치되고, 주사장치가 회전하는 축을 중심으로 회전하면서 항암제 바이알이 주사장치와 정렬될 수 있도록 아크(arc) 형상으로 항암제 바이알이 배치될 수 있도록 설치되는 제2고정부재;를 포함하는 것을 특징으로 하는 항암 주사제 조제장치.A second fixing member installed on the sterile preparation table and installed to allow the anticancer drug vial to be disposed in an arc shape so that the anticancer drug vial can be aligned with the injection device while rotating about the axis on which the injection device rotates. Anticancer injection preparation device characterized in that.
  4. 제 1항에 있어서,The method of claim 1,
    상기 주사장치는,The injection device,
    상기 약품공급부에서 항암제를 추출하기 위한 주사기;A syringe for extracting an anticancer agent from the drug supply unit;
    상기 주사기 하부에 설치되고, 주사기가 약품공급부에 설치된 항암제 바이알의 위치를 향해 회전 가능하게 하는 회전부;A rotating part installed below the syringe and allowing the syringe to rotate toward a position of an anticancer drug vial installed in the medicine supplying part;
    상기 회전부 상부에 설치되고, 주사기가 항암제 바이알의 위치를 향해 직선운동을 하도록 하는 제1리니어; 및A first linear installed at an upper portion of the rotating part to allow the syringe to linearly move toward the position of the anticancer drug vial; And
    상기 제1리니어 상부에 설치되고, 주사기의 피스톤을 동작시켜 항암제를 추출하거나 주입하도록 하는 제2리니어;를 포함하는 것을 특징으로 하는 항암 주사제 조제장치.And a second linear installed above the first linear to operate the piston of the syringe to extract or inject the anticancer agent.
  5. 제 1항에 있어서,The method of claim 1,
    상기 수액공급부는,The fluid supply unit,
    수액백이 설치되는 수액백 설치부;Sap bag installation unit is installed sap bag;
    상기 수액백 일측에 연결되어 수액백으로부터 추출된 수액이 이송하는 제1연결튜브;A first connection tube connected to one side of the sap bag and transferring the sap extracted from the sap bag;
    상기 제1연결튜브가 일측에 연결되고, 제1연결튜브를 통해 기설정된 정량만큼 수액백으로부터 추출되도록 펌핑하고 토출하는 정량펌프; 및A metering pump connected to one side of the first connecting tube and pumping and discharging the pump to be extracted from the sap bag by a predetermined amount through the first connecting tube; And
    상기 정량펌프에서 토출된 수액을 혼합부로 이송하기 위한 제2연결튜브;를 포함하는 것을 특징으로 하는 항암 주사제 조제장치.And a second connecting tube for transferring the sap discharged from the metering pump to the mixing unit.
  6. 제 5항에 있어서,The method of claim 5,
    대량의 항암제를 혼합용기로 주입하기 위해, 대량의 항암제가 저장된 항암제백이 수액백 설치부에 설치되고, 제1연결튜브는 상기 항암제백 일측에 연결되도록 설치되어, 정량펌프의 작동에 의해 대량의 항암제가 제2연결튜브를 통해 혼합용기로 주입될 수 있는 것을 특징으로 하는 항암 주사제 조제장치.In order to inject a large amount of anticancer agent into the mixing container, an anticancer agent bag containing a large amount of anticancer agent is installed in the infusion bag installation unit, and a first connection tube is installed to be connected to one side of the anticancer agent bag. Anticancer injection preparation device, characterized in that can be injected into the mixing vessel through the second connecting tube.
  7. 제 1항에 있어서,The method of claim 1,
    상기 혼합부에는,In the mixing section,
    혼합용기에 수용된 항암제와 수액의 중량을 확인하기 위해 제1전자저울이 더 설치되는 것을 특징으로 하는 항암 주사제 조제장치.An anticancer injection preparation device, characterized in that the first electronic balance is further installed to check the weight of the anticancer agent and the sap contained in the mixed container.
  8. 제 1항에 있어서,The method of claim 1,
    가루 형태의 항암제가 사용될 경우, 항암제에 수액을 주입하고 수액에 항암제가 용해될 수 있도록 혼합하기 위해 쉐이커가 더 설치되는 것을 특징으로 하는 항암 주사제 조제장치.When a powdered anticancer agent is used, a shaker is further provided for injecting the sap into the anticancer agent and mixing the mixture so that the anticancer agent can be dissolved in the sap.
  9. 제 1항에 있어서,The method of claim 1,
    항암 주사제 성분이 기재된 처방전 정보를 입력하고, 조제된 항암 주사제의 성분에 대한 정보를 입력하여, 데이터로 저장하기 위한 정보입력부를 더 포함하는 것을 특징으로 하는 항암 주사제 조제장치.An anticancer injection preparation device comprising: an input unit for inputting prescription information describing an anticancer injection ingredient, and inputting information on the ingredient of the prepared anticancer injection drug and storing the data as data.
  10. 제 9항에 있어서,The method of claim 9,
    상기 정보입력부는,The information input unit,
    병원전상망 연동을 통해 전달된 처방전 정보와 조제된 항암 주사제의 성분에 대한 정보를 바코드 라벨로 출력하는 바코드 출력기;A bar code printer for outputting the prescription information delivered through the hospital network and information on the components of the prepared anticancer injection drug as a bar code label;
    처방전 정보와 조제된 항암 주사제의 성분 정보를 읽기 위한 바코드 리더기; 및A barcode reader for reading prescription information and ingredient information of the prepared anticancer injection; And
    상기 바코드 리더기를 통해 입력된 정보를 표시하고 저장하며, 항암 주사제를 조제하는 곳과 병원전산망으로 정보를 전송하기 위한 터치스크린;을 포함하는 것을 특징으로 하는 항암 주사제 조제장치.And a touch screen for displaying and storing the information input through the barcode reader and transmitting the information to the place where the anticancer injection is prepared and the hospital computer network.
  11. 항암제가 수용된 복수개의 항암제 바이알이 고정되어 복수개의 항암제 바이알 중 어느 하나가 선택되어 항암제를 공급하는 약품공급부, 및 항암제와 수액을 혼합하기 위한 혼합용기를 공급하기 위한 공급부;A plurality of anticancer agent vials containing an anticancer agent is fixed to any one of a plurality of anticancer agent vials to supply a drug supply unit for supplying an anticancer agent, and a supply unit for supplying a mixed container for mixing the anticancer agent and the sap;
    상기 공급부로부터 공급되는 약품공급부와 혼합용기를 이용하여 항암 주사제를 조제하기 위한 제1항 내지 제10항 중 어느 하나의 항암 주사제 조제장치;An anticancer injection preparation device according to any one of claims 1 to 10 for preparing an anticancer injection using a medicine supplying unit and a mixing container supplied from the supply unit;
    상기 공급부로부터 공급되는 약품공급부와 혼합용기를 상기 항암 주사제 조제장치로 이송하거나 상기 항암 주사제 조제장치로부터 약품공급부와 항암 주사제가 수용된 혼합용기를 이송하기 위한 이송로봇; 및A transport robot for transporting the drug supply unit and the mixed container supplied from the supply unit to the anticancer injection preparation device or for transporting the mixed container containing the drug supply unit and the anticancer injection drug from the anticancer injection device; And
    상기 이송로봇에 의해 상기 항암 주사제 조제장치로부터 이송되는 약품공급부와 항암 주사제가 수용된 혼합용기를 반출하기 위한 반출부를 포함하는 항암 주사제 조제시스템.An anticancer injection preparation system comprising a drug supply unit transferred from the anticancer injection preparation device by the transfer robot and a carrying out portion for carrying out a mixed container containing the anticancer injection drug.
  12. 제11항에 있어서,The method of claim 11,
    상기 항암 주사제 조제장치를 복수개 포함하고,A plurality of anticancer injection preparation device,
    상기 항암 주사제 조제장치들은 각각 상기 이송로봇으로부터 이격된 이격거리가 동일한 위치에 위치하도록 설치되는 것을 특징으로 하는 항암 주사제 조제시스템.Wherein the anticancer injection preparation device is characterized in that the anti-cancer injection preparation system is installed so that the separation distance from the transport robot is located at the same position.
PCT/KR2017/008039 2015-12-09 2017-07-26 Anticancer injection preparation device and anticancer injection preparation system comprising same WO2018021816A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20150174659 2015-12-09
KR1020160094930A KR20170068368A (en) 2015-12-09 2016-07-26 Anticancer injectable preparation equipment and Anticancer injectable preparation system including the same
KR10-2016-0094930 2016-07-26

Publications (1)

Publication Number Publication Date
WO2018021816A1 true WO2018021816A1 (en) 2018-02-01

Family

ID=59279261

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2017/008039 WO2018021816A1 (en) 2015-12-09 2017-07-26 Anticancer injection preparation device and anticancer injection preparation system comprising same

Country Status (2)

Country Link
KR (1) KR20170068368A (en)
WO (1) WO2018021816A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112495849A (en) * 2020-12-31 2021-03-16 安徽联谊药业股份有限公司 Injection medicament screening washer is learned with western medicine

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050087562A1 (en) * 2003-10-08 2005-04-28 Akira Koide Mixed liquid manufacturing apparatus
US20080169044A1 (en) * 2006-10-20 2008-07-17 Forhealth Technologies, Inc. Automated drug preparation apparatus including syringe loading, preparation and filling
KR20110106671A (en) * 2010-03-23 2011-09-29 재단법인 포항지능로봇연구소 Apparatus for preparing medicine for syringe and method of preparing medicine for syringe
US20130085467A1 (en) * 2011-09-27 2013-04-04 Board Of Regents, The University Of Texas System Robotic infusion mixer and transportable cartridge
KR20160058070A (en) * 2013-09-19 2016-05-24 가부시키가이샤 유야마 세이사쿠쇼 Coinjection device and coinjection method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050087562A1 (en) * 2003-10-08 2005-04-28 Akira Koide Mixed liquid manufacturing apparatus
US20080169044A1 (en) * 2006-10-20 2008-07-17 Forhealth Technologies, Inc. Automated drug preparation apparatus including syringe loading, preparation and filling
KR20110106671A (en) * 2010-03-23 2011-09-29 재단법인 포항지능로봇연구소 Apparatus for preparing medicine for syringe and method of preparing medicine for syringe
US20130085467A1 (en) * 2011-09-27 2013-04-04 Board Of Regents, The University Of Texas System Robotic infusion mixer and transportable cartridge
KR20160058070A (en) * 2013-09-19 2016-05-24 가부시키가이샤 유야마 세이사쿠쇼 Coinjection device and coinjection method

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112495849A (en) * 2020-12-31 2021-03-16 安徽联谊药业股份有限公司 Injection medicament screening washer is learned with western medicine
CN112495849B (en) * 2020-12-31 2023-10-13 安徽联谊药业股份有限公司 Western medicine is learned with injection medicament screening ware

Also Published As

Publication number Publication date
KR20170068368A (en) 2017-06-19

Similar Documents

Publication Publication Date Title
ES2856339T3 (en) Robotic system for compounding drugs
CN103341335B (en) Automatic intravenous medicine dispensing equipment and swinging type rotating disc dispensing device
EP2285337B1 (en) Automated workstation for the secure preparation of a final product for medical or pharmaceutical use
EP2298270A1 (en) Medication mixing device and medication mixing method
CN110680653B (en) Desktop dispensing robot and dispensing method thereof
JP2016536079A5 (en)
US11897640B2 (en) Machine and process for preparing intravenous medicaments
WO2011045906A1 (en) System for assisting medicinal liquid preparation and method for assisting medicinal liquid preparation
US9433558B2 (en) Medicine transfusion apparatus and medicine transfusion method
CN104436354A (en) Automatic fluid preparation system and automatic fluid preparation machine used for preparing intravenous fluids
CN111803376B (en) Ampoule bottle medicine-based batch dispensing robot and dispensing method
WO2018021816A1 (en) Anticancer injection preparation device and anticancer injection preparation system comprising same
CN112263479A (en) Intravenous liquid medicine dispensing robot and operation system control medicine dispensing method thereof
JP2000356642A (en) Quality control system and quality control method for radioactive drug
JP2014171696A (en) Automatic preparation device for anticancer agent
WO2018004230A1 (en) Apparatus for preparing anticancer injection
CN217745057U (en) XiLin bottle encapsulation medicine allotment robot
CN203316053U (en) Automatic intravenous medicine compounding device and medicine compounding device using visual sensor
CN115040410A (en) Intelligent penicillin bottle liquid medicine blending robot system and medicine dispensing method
CN215133427U (en) Robot for blending intravenous liquid medicine
JP3684250B2 (en) Automatic sterility test operation device such as vials
WO2022188124A1 (en) Apparatus, system and corresponding method for pharmacy intravenous admixture
CN115919647A (en) Intelligent medicine dispensing robot
CN116943492A (en) Pre-dissolving mechanism for intravenous drug infusion
CN114452213A (en) XiLin bottle encapsulation medicine full-intelligent allotment robot

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17834757

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17834757

Country of ref document: EP

Kind code of ref document: A1